Document:

Exhibit 10.1

Exhibit
10.1

AMENDMENT

MEDCATH CORPORATION

OUTSIDE DIRECTORS’ STOCK OPTION PLAN

     THIS AMENDMENT to the MedCath Corporation Outside Directors’ Stock Option Plan (the
“Plan”) is made and adopted on March 5, 2008 by MEDCATH CORPORATION, a
Delaware corporation (the “Company”).

RECITALS

     WHEREAS, the Company has adopted the Plan; and

     WHEREAS, the Plan has been heretofore amended by instruments of the Company dated September
18, 2000, April 24, 2001 and March 5, 2002; and

     WHEREAS, the Company desires to further amend the Plan to (i) increase the number of shares as
to which options may be granted under the Plan, and (ii) extend the term of the Plan, and the Board
of Directors of the Company and the stockholders have approved such amendments;

     NOW THEREFORE, the Plan, as heretofore amended, is hereby further amended as follows:

     1. The first sentence of Section 4 of the Plan is amended in its entirety to read as follows:

	 	 	The stock which may be issued and sold under the Plan will be the Common Stock of
the Company, of a total number not exceeding five hundred fifty thousand (550,000)
shares, subject to adjustment as provided in Section 7.

     2. Section 10 of the Plan is amended in its entirety to read as follows:

     Section 10. Termination. Unless otherwise terminated by the Board in
accordance with Section 9, this Plan shall terminate on October 31, 2012.

     3. Except as expressly or by necessary implication amended hereby, the Plan shall continue in
full force and effect.

 

 

     IN WITNESS WHEREOF, the Company has caused this Amendment to be executed as of the day and
year first above written.

	 	 	 	 	 
	 

	 	MEDCATH CORPORATION
	 
	 	 	 	 
	 

	 	By:	 	/s/ Edwin O. French
	 

	 	 	 	 
	 

	 	 	 	Edwin O. French, PresidentExhibit 10.2

Exhibit
10.2

ASSET PURCHASE AGREEMENT

BY AND BETWEEN

HEART HOSPITAL OF DTO, LLC

AND

GOOD SAMARITAN HOSPITAL

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	ARTICLE 1 TRANSFER OF ASSETS
	 	 	1	 
	 
	 	 	 	 
	1.1 Sale of Assets
	 	 	1	 
	1.2 Excluded Assets
	 	 	3	 
	1.3 Assumption of Liabilities
	 	 	4	 
	1.4 Excluded Liabilities
	 	 	5	 
	1.5 Purchase Price; Noncompetition Consideration
	 	 	6	 
	1.6 Closing; Effective Time
	 	 	6	 
	1.7 Tax Allocation
	 	 	6	 
	1.8 Conveyances
	 	 	7	 
	 
	 	 	 	 
	ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF SELLER
	 	 	7	 
	 
	 	 	 	 
	2.1 Organization, Corporate Power and Authority
	 	 	7	 
	2.2 No Breach
	 	 	8	 
	2.3 Assets
	 	 	8	 
	2.4 Inventory
	 	 	8	 
	2.5 No Outstanding Rights
	 	 	8	 
	2.6 Personal Property Leases
	 	 	9	 
	2.7 Real Property
	 	 	9	 
	2.8 Structural Defects; Condition of Real Property
	 	 	10	 
	2.9 Government Reimbursement Participation; Health Care Law Compliance
	 	 	11	 
	2.10 No Violation of Law
	 	 	12	 
	2.11 Legal Proceedings
	 	 	12	 
	2.12 Fees and Commissions
	 	 	12	 
	2.13 Material Contracts
	 	 	12	 
	2.14 Insurance
	 	 	13	 
	2.15 Tax Matters
	 	 	13	 
	2.16 Environmental Matters
	 	 	13	 
	2.17 Absence of Certain Changes or Events
	 	 	13	 
	2.18 Employees
	 	 	16	 
	2.19 Financial Information
	 	 	17	 
	2.20 Intellectual Property
	 	 	18	 
	2.21 Completeness of Disclosure
	 	 	18	 
	 
	 	 	 	 
	ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF BUYER
	 	 	19	 
	 
	 	 	 	 
	3.1 Organization, Corporate Power and Authority
	 	 	19	 
	3.2 No Breach
	 	 	19	 
	3.3 Legal Proceedings
	 	 	19	 
	3.4 Fees and Commissions
	 	 	20	 
	3.5 Funding of Purchase Price
	 	 	20	 

-i-

 

TABLE OF CONTENTS

(continued)

	 	 	 	 	 
	 	 	Page	 
	ARTICLE 4 CONDITIONS TO THE OBLIGATIONS OF BUYER
	 	 	20	 
	 
	 	 	 	 
	4.1 Representations and Warranties to be True and Correct
	 	 	20	 
	4.2 Covenants
	 	 	20	 
	4.3 No Action or Proceeding
	 	 	20	 
	4.4 Seller’s Closing Deliverables
	 	 	20	 
	4.5 No Material Casualty
	 	 	22	 
	 
	 	 	 	 
	ARTICLE 5 CONDITIONS TO THE OBLIGATIONS OF SELLER
	 	 	22	 
	 
	 	 	 	 
	5.1 Representations and Warranties to be True and Correct
	 	 	22	 
	5.2 Performance
	 	 	23	 
	5.3 No Action or Proceeding
	 	 	23	 
	5.4 Buyer’s Closing Deliverables
	 	 	23	 
	 
	 	 	 	 
	ARTICLE 6 ADDITIONAL AGREEMENTS
	 	 	24	 
	 
	 	 	 	 
	6.1 Retention and Access to Records
	 	 	24	 
	6.2 Access to Acquired Assets; Contracts
	 	 	24	 
	6.3 Misdirected Payments
	 	 	26	 
	6.4 Cooperation on Tax Matters
	 	 	26	 
	6.5 Third Party Litigation Cooperation
	 	 	26	 
	6.6 Confidentiality; Publicity
	 	 	27	 
	6.7 Cooperation
	 	 	28	 
	6.8 Costs and Charges
	 	 	28	 
	6.9 Employees
	 	 	29	 
	6.10 Medicare and Medicaid Cost Reports
	 	 	31	 
	6.11 Non-Competition and Non-Solicitation
	 	 	31	 
	6.12 Change of Name
	 	 	33	 
	6.13 Contact with Employees and Vendors
	 	 	33	 
	6.14 Conduct of the Company
	 	 	33	 
	6.15 Billing for Transition Patients
	 	 	33	 
	 
	 	 	 	 
	ARTICLE 7 TERMINATION
	 	 	34	 
	 
	 	 	 	 
	7.1 Termination
	 	 	34	 
	7.2 Effect of Termination
	 	 	35	 
	7.3 Disposition of Deposit Upon Termination
	 	 	35	 
	 
	 	 	 	 
	ARTICLE 8 INDEMNIFICATION
	 	 	35	 
	 
	 	 	 	 
	8.1 Survival
	 	 	35	 
	8.2 Indemnification — General
	 	 	35	 
	8.3 Method of Asserting Claims
	 	 	36	 
	8.4 Continued Liability for Indemnity Claims
	 	 	37	 
	8.5 Limitations on and Expiration of Indemnification
	 	 	38	 

-ii-

 

TABLE OF CONTENTS

(continued)

	 	 	 	 	 
	 	 	Page	 
	ARTICLE 9 MISCELLANEOUS
	 	 	39	 
	 
	 	 	 	 
	9.1 No Shop
	 	 	39	 
	9.2 Amendments
	 	 	40	 
	9.3 Waiver
	 	 	40	 
	9.4 Notices
	 	 	40	 
	9.5 Counterparts
	 	 	41	 
	9.6 Enforceability and Severability
	 	 	41	 
	9.7 Governing Law
	 	 	41	 
	9.8 Assignment
	 	 	41	 
	9.9 Expenses
	 	 	42	 
	9.10 Parties in Interest
	 	 	42	 
	9.11 Consents
	 	 	42	 
	9.12 Third Parties
	 	 	42	 
	9.13 Entire Agreement
	 	 	42	 
	9.14 Specific Performance; Injunctive Relief
	 	 	42	 
	9.15 Headings; Construction
	 	 	42	 
	9.16 Applicable Date
	 	 	42	 
	9.17 No Payments for Referrals
	 	 	42	 
	9.18 Dispute Resolution
	 	 	43	 
	9.19 Specific Controls Over the General
	 	 	44	 
	9.20 Construction
	 	 	44	 
	9.21 Incorporation of Exhibits and Schedules
	 	 	44	 
	9.22 Execution by Investor Members
	 	 	44	 

-iii-

 

INDEX TO EXHIBITS AND SCHEDULES

Exhibits

	 	 	 
	Exhibit A

	 	Capitalized Terms
	Exhibit B

	 	Environmental Report
	Exhibit C

	 	Bill of Sale and Assignment
	Exhibit D

	 	Assignment and Assumption Agreement
	Exhibit E

	 	Limited Warranty Deed
	Exhibit F

	 	Transition Services Agreement

Schedules

	 	 	 
	Schedule 1.1(a)

	 	Personal Property
	Schedule 1.1(b)

	 	Personal Property Leases
	Schedule 1.1(c)

	 	Owned Real Property
	Schedule 1.1(e)

	 	Real Property Leases
	Schedule 1.1(f)

	 	Licenses
	Schedule 1.1(g)

	 	Computer Software
	Schedule 1.1(i)

	 	Prepaid Expenses
	Schedule 1.1(k)

	 	Intellectual Property Exceptions
	Schedule 1.2(a)

	 	Excluded Contracts
	Schedule 1.2(d)

	 	Other Excluded Assets
	Schedule 1.2(i)

	 	Excluded Computer Software and Hardware
	Schedule 1.5(c)

	 	Noncompetition Compensation Distribution
	Schedule 1.7

	 	Tax Allocation
	Schedule 1.8

	 	Permitted Real Property Encumbrances
	Schedule 2.1(c)

	 	Shareholders
	Schedule 2.2

	 	Restrictions on Seller’s Authority
	Schedule 2.3(a)

	 	Third Party Interests in Acquired Assets
	Schedule 2.4

	 	Inventory
	Schedule 2.5

	 	Outstanding Rights Affecting Acquired Assets
	Schedule 2.6(b)

	 	Leased Equipment
	Schedule 2.7(d)

	 	Compliance with Property Legal Requirements
	Schedule 2.9

	 	Government Reimbursement Program Investigations
	Schedule 2.11

	 	Seller’s Legal Proceedings
	Schedule 2.13

	 	Material Contracts
	Schedule 2.14

	 	Insurance
	Schedule 2.15

	 	Tax Matters
	Schedule 2.17(a)

	 	Certain Changes or Events
	Schedule 2.17(b)

	 	Conduct of Operations
	Schedule 2.18(a)

	 	Employees
	Schedule 2.18(b)

	 	Employee Benefit Plans
	Schedule 2.19

	 	Historical Financial Information
	Schedule 2.20

	 	Intellectual Property
	Schedule 3.2

	 	Restrictions on Buyer’s Authority
	Schedule 3.3

	 	Buyer’s Legal Proceedings

-i-

 

INDEX TO EXHIBITS AND SCHEDULES

(continued)

	 	 	 
	Schedule 6.2(c)(i)

	 	Existing Contracts
	Schedule 6.2(c)(ii)

	 	Buyer Determined Contracts
	Schedule 6.9(a)

	 	Excluded Employees

-ii-

 

ASSET PURCHASE AGREEMENT

     THIS ASSET PURCHASE AGREEMENT (the “Agreement”), is entered into as of the date below written
(the “Execution Date”), by and between Heart Hospital of DTO, LLC, a Delaware limited liability
company d/b/a Dayton Heart Hospital (“Seller”), and Good Samaritan Hospital, an Ohio public benefit
corporation (“Buyer”). Defined terms used but not otherwise defined herein shall have the meanings
contained in Exhibit A hereto.

WITNESSETH

     WHEREAS, Seller desires to sell (subject to the assumption by Buyer of certain specifically
enumerated liabilities), and Buyer desires to purchase, substantially all of Seller’s assets; and

     WHEREAS, the Parties desire to enter into this Agreement for the purpose of setting forth
their mutual rights and obligations with respect to the foregoing.

     NOW, THEREFORE, for good and valuable consideration, the receipt, adequacy and sufficiency of
which are hereby acknowledged and accepted, and in consideration of the premises and mutual
promises herein contained, the Parties, intending to be legally bound, hereby agree as follows:

ARTICLE 1

TRANSFER OF ASSETS

     1.1 Sale of Assets. At the Closing and subject to the terms and conditions of this
Agreement, other than the Excluded Assets, Seller shall sell, transfer, convey, assign and deliver
to Buyer, and Buyer shall purchase from Seller, all rights, title, and interest in and to all
assets of every description, and whether real, personal or mixed, tangible or intangible, owned or
leased by Seller and held or used in the Seller’s Business, including the following items
(collectively, the “Acquired Assets”):

     (a) All tangible personal property, including all equipment, furniture, fixtures, machinery,
vehicles, office furnishings, instruments, leasehold improvements, spare parts and, to the extent
assignable or transferable, all rights in all warranties of any manufacturer or vendor with respect
thereto owned by Seller or otherwise employed in the conduct and operation of the Business
(collectively, the “Personal Property”), including the Personal Property described on
Schedule 1.1(a).

     (b) All leases, leasehold interests or other contractual rights relating to the Personal
Property used in the operation of the Business (whether as (sub)lessor or (sub)lessee) (the
"Personal Property Leases”) to which Seller is a Party, including the Personal Property Leases
described on Schedule 1.1(b).

 

 

     (c) Good and marketable title in fee simple absolute to the Owned Real Property described on
Schedule 1.1(c), and, to the extent permitted by law, any rights of Seller against third
parties under general warranty deeds, related to any such Owned Real Property, together with all
plants, buildings, structures, improvements, construction in progress, appurtenances, covenants,
easements, servitudes and fixtures situated thereon, forming a part thereof, or in any manner
belonging to or pertaining to such interests of Seller.

     (d) All Contracts and contract rights of Seller relating to the Acquired Assets or the
Business of any type or nature as determined in accordance with the procedures set forth in
Section 6.2, but excluding the Excluded Contracts (all such assigned Contracts, the
"Assumed Contracts”).

     (e) All real property leases, leasehold interests or other contractual rights, interests,
easements and appurtenances relating to the Business (whether as (sub)lessor or (sub)lessee) (the
“Real Property Leases”) to which Seller is a Party, including the Real Property Leases described on
Schedule 1.1(e).

     (f) To the extent transferable or assignable and subject to any applicable consent
requirements, rights to all state, federal, special or local licenses or permits (including, but
not limited to, air, water or other environmental licenses and permits), rights, certificates of
need, certificates of exemption, franchises, accreditations, registrations, permits, approvals and
consents, and all applications therefor and waivers of any requirements pertaining thereto (each a
“License” and collectively, the “Licenses”), if any, issued to Seller for the Acquired Assets or
the Business, including the Licenses described on Schedule 1.1(f).

     (g) All computer hardware and data processing equipment held by Seller or used primarily in
the conduct of its Business or the operation of the Acquired Assets, and, to the extent assignable
or transferable, all rights in all warranties of any manufacturer or vendor with respect thereto
and the computer software listed on Schedule 1.1(g);

     (h) All inventories of usable goods and supplies of the Business owned by or, with respect to
consigned goods and supplies, owned by Seller, including pharmaceuticals and medications, food,
janitorial supplies, office supplies, forms, consumables, disposables, linens, and medical
supplies, existing and wherever located (collectively, the “Purchased Inventory”).

     (i) The deposits, escrows, prepaid expenses or other advance payments of Seller relating to
the Business which are assumable and usable by Buyer listed on Schedule 1.1(i)
(collectively, the “Prepaid Expenses”).

     (j) To the extent transferable or assignable and subject to any applicable consent
requirements, all documents, books, records, operating and policy manuals and files owned by
Seller, pertaining to or used primarily in connection with the Business, operations of Seller or
the Acquired Assets, whether in hard copy or other form, including all patient records, medical
records, medical staff records, clinical records, financial records, equipment records and medical
and administrative libraries, personnel records and purchase and vendor records, existing and
wherever located (collectively, the “Transferred Records”), but excluding the Excluded Records,
subject to the Parties’ rights under Section 6.1.

- 2 -

 

     (k) To the extent held or used in or ancillary to the Business or operation of the Acquired
Assets, trademarks, trade names, service marks, copyrights and any applications therefor, mask
works, net lists, schematics, technology, know-how, trade secrets ideas, algorithms, process,
domain names or intangible proprietary information or material set forth on
Schedule 1.1(k).

     (l) The names, logos and symbols used by Seller in connection with the Business or the
Acquired Assets, including the name “Dayton Heart Hospital,” all goodwill associated with the
Business of Seller as a going concern, all warranties (express or implied) and all telephone and
facsimile numbers as currently used by Seller primarily in support of the Business.

     (m) Any insurance proceeds and insurance proceeds receivable (including applicable
deductibles, co-payments or self-insured requirements) arising from the Acquired Assets to the
extent provided in Section 4.5.

     (n) All claims of Seller against third parties, choate or inchoate, known or unknown,
contingent or otherwise, relating to the Acquired Assets.

     1.2 Excluded Assets. Notwithstanding anything to the contrary, Seller is not selling,
and Buyer is not purchasing or assuming obligations with respect to, the following assets which
shall remain the property of Seller after the Closing (the “Excluded Assets”):

     (a) All rights under Contracts identified on Schedule 1.2(a) as excluded from this
Agreement pursuant to those procedures set forth in Section 6.2 together with any Employee
Benefit Plan of any nature whatsoever applicable to Seller’s employees (except that Buyer shall
have liability for and to the extent provided in Section 6.9) and all contracts with any
Government Reimbursement Program or other third-party payor or other party that reimburses Seller
for the provision of medical services (collectively, the “Excluded Contracts”).

     (b) The corporate record books, minute books, corporate seals and tax records of Seller and
all records of any kind that Seller is required by Legal Requirements to retain in its own
possession together with those records maintained by MedCath with respect to its Affiliates
(including Seller) that reflect the consolidated purchase of goods and services by MedCath for such
Affiliates (collectively, the “Excluded Records”), subject to the Parties’ rights under
Section 6.1.

     (c) All claims of Seller against third parties, choate or inchoate, known or unknown,
contingent or otherwise, relating to the Excluded Assets.

     (d) Such other property and assets, if any, specifically described on Schedule 1.2(d).

     (e) With respect to the amount by which any retrospective settlement of any cost report
exceeds such original cost report relating to a period prior to the Effective Time, all rights of
Seller now existing or which may hereafter exist with respect to any payment or reimbursement owed
to Seller by any Government Reimbursement Program or other payor which is attributable to any
period of time prior to the Effective Time.

     (f) All rights of Seller under this Agreement or any agreement contemplated hereby.

- 3 -

 

     (g) All claims for refunds of Taxes, if any, and other governmental charges (other than those
contained in Section 1.2(e) above) of whatever nature.

     (h) All personnel records and other books and records (or copies thereof, as applicable) that
Seller is required by law to retain in its possession; provided, however, that the originals or
copies of all such records shall be provided to Buyer at the Closing.

     (i) All computer software and hardware listed on Schedule 1.2(i).

     (j) All cash, cash equivalents, short term investments, investments in debt securities limited
as to use under indenture agreements, investments in fixed income securities, and deposits to fund
unemployment benefits, and the accounts in which those assets are deposited.

     (k) All accounts receivable of Seller, and all rights to payment, whether billed or unbilled,
recorded or unrecorded, accrued and existing, whether or not written off, as of the Effective Time
with respect to the Business, including, without limitation, rights to payment for all goods and
services that Seller provides at the Hospital to its patients prior to the Effective Time subject
to Section 6.15 (collectively, the “Accounts Receivable”).

     (l) All provider numbers and related agreements related to any Government Reimbursement
Programs.

     (m) All bank accounts of Seller.

     (n) The name “MedCath” and all rights related thereto.

     1.3 Assumption of Liabilities. As of the Effective Time, Buyer shall assume and agree
to pay, discharge and perform according to their terms only the following liabilities and
obligations of Seller (collectively, the “Assumed Liabilities”):

     (a) All liabilities and obligations arising out of operation of the Business or the use or
ownership of the Acquired Assets from and after the Effective Time.

     (b) All liabilities and obligations under or arising out of the Assumed Contracts and the Real
Property Leases; provided, however, Buyer shall not assume any liabilities or obligations arising
out of or in connection with Seller’s breach or alleged breach of such Assumed Contracts or Real
Property Leases which occurred prior to the Effective Time.

     (c) All liabilities and obligations arising under any Licenses from and after the Effective
Time, to the extent such liabilities and obligations relate solely to Buyer’s use or ownership of
the Business or the Acquired Assets, except to the extent that such liabilities and obligations
otherwise constitute Excluded Liabilities or Excluded Assets.

     (d) Notwithstanding Sections 1.2(a) and 1.4(d) to the contrary, all
liabilities and obligations of Seller as of the Effective Time for accrued paid time off expenses,
whether for vacation sick pay or otherwise (collectively, the “Accrued PTO”), attributable to the
Transferred Employees; provided, however, that Seller shall pay to Buyer in immediately available
funds as of the Effective Time an amount equal to the Accrued PTO expenses attributable to the

- 4 -

 

Transferred Employees reflected on the Seller’s books as of the Closing Date or arising from
its operation of the Business prior to the Effective Time.

     (e) All obligations to provide patient care to existing patients of the Hospital as of the
Closing Date.

     1.4 Excluded Liabilities. Except for the Assumed Liabilities, Buyer shall not assume
or become liable or obligated in any way and Seller shall retain and remain solely liable for any
obligation to pay, perform and discharge all Liabilities of Seller, regardless of when asserted,
including without limitation, any of the following (collectively, the “Excluded Liabilities”):

     (a) Any obligations or liabilities of Seller under the Excluded Contracts.

     (b) Obligations or liabilities of Seller by reason of any failure to comply with the rules and
regulations of any Government Reimbursement Program which is attributable to any period of time
ending prior to the Effective Time.

     (c) Any obligation or liability of Seller arising out of or relating to any violation of any
Legal Requirements prior to the Effective Time.

     (d) Any obligation or liability of Seller arising out of or relating to any Employee Benefit
Plan of any nature whatsoever maintained by Seller or its Affiliates for the benefit of its or
their employees (except that Buyer shall have liability for and to the extent provided in
Section 6.9).

     (e) Any accounts payable reflected on the Seller’s books as of the Closing Date or arising
from the operation of the Business prior to the Effective Time, subject to the terms of
Sections 1.3(d) and 1.4(g).

     (f) With respect to any retrospective settlement of any cost report for an amount less than
such original cost report relating to a period ending prior to the Effective Time, all obligations
of Seller now existing or which may hereafter exist with respect to any payment or reimbursement
owed by Seller to any Government Reimbursement Program or other payor which is attributable to any
period of time ending prior to the Effective Time.

     (g) Obligations or liabilities for Taxes, including, without limitation, (1) any Taxes arising
as a result of Seller’s operation of the Business or ownership of the Acquired Assets prior to the
Effective Time; (2) any Taxes that will arise as a result of the sale of the Acquired Assets
pursuant to this Agreement; and (3) any deferred Taxes of any nature; provided however, it is
acknowledged that Buyer shall have the obligation to pay its proportionate share of all real and
personal property Taxes due as a result of the ownership or operation of the Acquired Assets
following the Effective Time.

     (h) Obligations or liabilities to Government Reimbursement Programs for overpayments and other
financial obligations arising from adjustments or reductions in reimbursement attributable to
events, transactions, circumstances, or conditions occurring or existing prior to the Effective
Time.

- 5 -

 

     (i) Seller’s expenses relating to this Agreement.

     (j) All professional liability claims or other claims for acts or omissions of Seller.

     1.5 Purchase Price; Noncompetition Consideration.

     (a) Subject to the terms of this Agreement, the consideration payable by Buyer for the
Acquired Assets will be an amount equal to Forty-Seven Million Five Hundred Thousand Dollars
($47,500,000) (the “Purchase Price”).

     (b) Prior to the date hereof, a deposit of One Million Dollars ($1,000,000) (“Buyer’s
Deposit”) has been delivered by Buyer to Michael J. Burdge, Esq. (the “Escrow Agent”) under the
terms of the Escrow Agreement by and among Escrow Agent, Seller and Buyer dated as of March 4,
2008, as modified by that certain Letter Agreement, dated as of the date hereof (collectively, the
"Escrow Agreement”). Upon the closing of the transaction contemplated by this Agreement, the
Escrow Agent shall deliver the Buyer’s Deposit to Seller and such funds shall be applied to the
Purchase Price. If the transaction contemplated by this Agreement is not consummated as set forth
in this Agreement, the Buyer’s Deposit shall be disbursed by the Escrow Agent in accordance with
the terms of the Escrow Agreement and Section 7.3.

     (c) At Closing, Buyer shall pay an aggregate amount equal to Seven Million Five Hundred
Thousand Dollars ($7,500,000) (the “Noncompetition Compensation”) as consideration for the
execution of this Agreement by MedCath and each Investor Member who is an individual for purposes
of acknowledging the application of, and agreeing to be bound by, those terms and conditions set
forth in Sections 6.11 and 9.17. Such Noncompetition Compensation shall be
distributed by Buyer to MedCath and each such Investor Member in such amounts set forth on
Schedule 1.5(c).

     1.6 Closing; Effective Time.

     (a) The closing of the transactions contemplated by this Agreement shall take place at 10
a.m., local time, at 325 John H. McConnell Blvd., Suite 600, Columbus, Ohio, on May 16, 2008, or at
such other time and date and/or at such other location as the Parties may mutually designate in
writing (such closing being called the “Closing” and such date being called the “Closing Date”).

     (b) The transactions contemplated by this Agreement shall be effective as of 11:59 p.m. on May
17, 2008 (“Effective Time”).

     (c) At the Closing, Seller shall deliver to Buyer the Seller’s Closing Documents.

     (d) At the Closing, Buyer shall deliver to Seller the payment of the Purchase Price and the
Buyer’s Closing Documents.

     1.7 Tax Allocation. The Purchase Price will be allocated among the Acquired Assets
for all Tax purposes in accordance with Section 1060 of the Code as described on
Schedule 1.7 hereto. After the Closing, the Parties shall make consistent use of such
allocation for all Tax purposes and in any Tax Returns filed with the Internal Revenue Service in
respect thereof,

- 6 -

 

including IRS Form 8594. In any Proceeding related to the determination of any Tax, neither
Buyer nor Seller shall contend or represent that such allocation is not a correct allocation.

     1.8 Conveyances. Conveyance of the Real Property to Buyer shall be by limited
warranty Deed subject only to the Permitted Real Property Encumbrances (as defined below).
Conveyance of the Personal Property shall be by a Bill of Sale and Assignment between Seller and
Buyer. “Permitted Real Property Encumbrances” shall mean: (a) public and utility easements, rights
of ingress and egress and building lines and use or occupancy restrictions and covenants of record;
(b) liens for Taxes that are not yet due and payable on the Closing Date; (c) such other title
matters existing prior to the Effective Time that are created by or with the written consent of
Buyer; (d) minor survey exceptions, reciprocal and utility easement agreements and other customary
encumbrances on title to real property that do not individually or in the aggregate diminish the
value or use of such property in any material respect; (e) zoning, use and building laws,
regulations, ordinances and codes of any Governmental Authority or agency applicable to the Real
Property; and (f) those additional encumbrances identified in Schedule 1.8.

ARTICLE 2

REPRESENTATIONS AND WARRANTIES OF SELLER

     As of the Execution Date and again as of the Closing Date, Seller represents and warrants to
Buyer that, except as contained in the disclosure Schedules attached hereto and incorporated
herein:

     2.1 Organization, Corporate Power and Authority.

     (a) Seller is a limited liability company duly formed, validly existing and in good standing
under the laws of the State of North Carolina and is duly qualified to do business and is in good
standing under the laws of the State of Ohio. Seller has the corporate power and authority to own,
lease and operate and hold its properties and to carry on its Business as now conducted.

     (b) Seller has full corporate power and authority to execute, deliver and perform the
corporate obligations and covenants contained in this Agreement and Seller’s Closing Documents and
to carry out the transactions contemplated hereby and thereby. The execution and delivery of this
Agreement and Seller’s Closing Documents by Seller and the consummation of the transactions
contemplated hereby and thereby have been duly authorized by all necessary corporate action on the
part of Seller. This Agreement constitutes the legal, valid and binding obligation of Seller,
enforceable in accordance with its terms, subject to applicable Exceptions. Each of Seller’s
Closing Documents, when duly executed and delivered by Seller and the other Parties thereto, will
constitute the legal, valid and binding obligation of Seller enforceable in accordance with its
respective terms, subject to applicable Exceptions.

     (c) Schedule 2.1(c) sets forth (i) a true and complete list of each Person who owns,
directly or indirectly, five percent (5%) or more of any class of equity interest of Seller,
provided that nothing herein shall require a listing of the shareholders of MedCath Corporation and
(ii) all

- 7 -

 

trustees, directors, managers and executive officers of Seller. Except as set forth on
Schedule 2.1(c), Seller has no equity, investment or other interest in any Person.

     2.2 No Breach. Except as described on Schedule 2.2, neither the execution and
delivery of this Agreement and related agreements contemplated herein by Seller nor the
consummation or performance of the transactions contemplated hereby or in the Seller’s Closing
Documents will, directly or indirectly (with or without notice, lapse of time or both): conflict
with or result in any violation of or constitute a breach or default under any term of (A) the
respective charter documents, bylaws, the articles of organization, operating agreements or other
organizational documents of Seller, (B) any Contract, permit or other instrument to which Seller is
a party, or by which Seller is bound or to which the Business or any of the Acquired Assets is
subject, assuming however all third party consents to assignments of Contracts have been obtained,
(C) any judgment to which Seller, the Business or any of the Acquired Assets is bound or subject,
or (D) any Legal Requirement, (ii) will not result in the creation of any lien or other encumbrance
upon the Business or any property which is required to be part of the Acquired Assets, and (iii) do
not require any notice to or any permit, authorization, consent or approval of any Governmental
Authority or of any other Person.

     2.3 Assets.

     (a) Except as described on Schedule 2.3(a), Seller is the sole and exclusive legal and
equitable owner of all right, title and interest in, has good and marketable title in fee simple
absolute to, and is in possession of all Acquired Assets. Except as described on
Schedule 2.3(a), no Affiliate of Seller or any Person has any direct or indirect ownership,
leasehold or other interest in the Acquired Assets. As of the Closing Date, all of the Acquired
Assets are free and clear of any encumbrances, except for Permitted Real Property Encumbrances.

     (b) The Acquired Assets and the Excluded Assets constitute all assets which are held or used
by Seller in the conduct of the Business and operation of the Hospital. The Acquired Assets
constitute all assets that are necessary for Buyer to conduct the Business and operation of the
Hospital as currently conducted subject to exclusion of the Excluded Assets.

     2.4 Inventory. The items of inventory of Seller as of the Effective Time (i) are (and
will be) of a quality and quantity useable or saleable in the ordinary course and are (and will be)
of a quantity sufficient to enable Buyer and its Affiliates to carry on the Business as currently
conducted, (ii) are (and will be) not in excess of reasonable quantities for anticipated sale in
the ordinary course and, except as set forth in Schedule 2.4, carried at amounts which
reflect valuations pursuant to the Seller’s normal inventory valuation policy and in accordance
with GAAP and (iii) do not include any obsolete or defective materials or any inventory items which
should be written off or written down for which there is not an adequate reserve calculated in
accordance with GAAP.

     2.5 No Outstanding Rights. Except as described on Schedule 2.5, there are no
outstanding rights (including any right of first refusal), interests, options or Contracts giving
any Person any current or future right to obtain an equity interest in Seller or to require Seller
or, from and after the Effective Time, Buyer, to sell or transfer to such Person or to any third
party any interest in any of the Acquired Assets.

- 8 -

 

     2.6 Personal Property Leases.

     (a) Schedule 1.1(b) is an accurate and complete list of all Personal Property Leases
(but excluding the Equipment Leases set forth in Schedule 1.1(b)). The Seller does not
have any liability with respect to any of such Personal Property Leases except as expressly set
forth therein.

     (b) Equipment Leases. Schedule 2.6(b) is an accurate and complete list of all
equipment leased or subleased by Seller or any of its Affiliates (the listed equipment being
collectively called the “Leased Equipment”), including identification of the lease or sublease
affecting such Leased Equipment or any interest therein to which the Seller or any of its
Affiliates now are a party or by which any of such entity’s interests in the Leased Equipment is or
will be bound. Neither the Seller nor any of its Affiliates have entered into a Contract and made
a commitment to lease equipment other than as disclosed in Schedule 2.6(b). Seller and/or
its Affiliates are in peaceable possession of the Leased Equipment and have exclusive use of the
Leased Equipment. Except as disclosed on Schedule 2.6(b), none of such Leased Equipment is
subject to any licenses, use restrictions, exceptions, reservations, limitations or other
impediments which adversely affect the value to the Business of the leasehold interest therein or
which interfere with or impair the present and continued use thereof in the usual and normal
conduct of the Business as currently conducted. Except as disclosed on Schedule 2.6(b),
none of such Leased Equipment which involves a payment in excess of $25,000 per annum is subject to
any lien (except liens for current taxes not yet due and payable, and liens to be discharged prior
to the Effective Time by Seller) which could, by foreclosure or enforcement, terminate or otherwise
adversely affect any Personal Property Lease to which the Leased Equipment is subject.

     2.7 Real Property.

     (a) Schedule 1.1(e) sets forth an accurate and complete list of all Real Property
Leases, including identification of the lease or sublease to which Seller or any of its Affiliates
is a party or by which any of such entity’s interests in real property is bound affecting such real
estate or any interest therein. Except as described on Schedule 1.1(e), neither the Seller
nor any of its Affiliates leases any real property used in conjunction with the operation of the
Business. Seller has made available to Buyer accurate, correct and complete copies of all Real
Property Leases and all amendments thereto. Neither Seller nor any of its Affiliates have (i) any
material liability with respect to any Real Property Lease except as expressly set forth therein,
or (ii) received any notice from any other party to any Real Property Leases of any uncured
defaults. Seller and/or each Affiliate is in peaceable possession of the real property subject to
the Real Property Leases (“Leased Real Property”)(other than exceptions of record that do not
materially interfere with the use of such property for its intended purpose) and none of the Leased
Real Property is subject to any easements, rights of way, licenses, grants, building or use
restrictions, exceptions, reservations, limitations or other impediments which materially interfere
with or impair the present and continued use thereof in the usual and normal conduct of the
Business as currently conducted. The Leased Real Property is not subject to any other leases or
tenancies of any nature whatsoever.

- 9 -

 

     (b) Schedule 1.1(c) sets forth an accurate and complete list of each parcel
constituting the Owned Real Property, and, with respect to each such parcel, includes its street
address, if any. Except as set forth in Schedule 1.1(c) and, except for Permitted Real
Property Encumbrances, there are no contracts or agreements, oral or written, relating to or
affecting the Owned Real Property that would affect or restrict rights to ownership or use or any
interest therein. Except as set forth on Schedule 1.1(c) and subject to the Permitted Real
Property Encumbrances, Seller is the sole and exclusive legal and equitable owner of all right,
title and interest in and has good and marketable title in fee simple absolute to and is in
possession of all Owned Real Property, including the buildings, structures and improvements
situated thereon and appurtenances thereto, in each case as of the Effective Time free and clear of
all Liens other than Permitted Real Property Encumbrances.

     (c) Neither the whole nor any portion of any Owned Real Property or Leased Real Property
(together with the rights to extract aggregate, collectively, “Real Property”) has been condemned,
requisitioned or otherwise taken by any public authority, no notice of any such condemnation,
requisition or taking has been received, and no such condemnation, requisition or taking of the
Real Property is threatened in writing.

     (d) Except as set forth on Schedule 2.7(d), Seller has received no written notice from
any Governmental Authority that either the Owned Real Property or the Leased Real Property is not
in compliance with all applicable Legal Requirements, and Seller has received no written notice
from any Governmental Authority that the buildings, structures, other improvements and fixtures on
such Real Property and the operations of the Business in or about any Real Property therein
conducted do not conform to all Legal Requirements. Schedule 2.7(d) sets forth all of the
Real Property for which permits and licenses have been or are being obtained. Seller has all
easements and rights reasonably necessary or appropriate to conduct the Business at the Real
Property.

     (e) None of the utility companies serving any building or facility of Seller has threatened
Seller in writing with any reduction in service. All installation and connection charges have been
paid for in full.

     (f) Seller has not filed any challenges or appeals regarding the amount of taxes on, or the
assessed valuation of, the Real Property, and Seller has not made any special arrangements or
agreements with any Governmental Authority with respect thereto. There is no tax assessment (which
is in addition to the normal, annual general real estate tax assessment) pending or threatened with
respect to any portion of the Real Property.

     2.8 Structural Defects; Condition of Real Property. Seller has received no written
notice from an architect, engineer or Governmental Authority that there are structural defects in
any improvement or structure situated on the Real Property which would prevent Buyer from
conducting the Business following the Effective Time as currently conducted, except for routine
maintenance and repairs which occur in the ordinary course

- 10 -

 

     2.9 Government Reimbursement Participation; Health Care Law Compliance.

     (a) Seller is eligible to receive payment without restriction under Title XVIII of the Social
Security Act (“Medicare”) and is a “provider” with valid and current provider agreements with one
or more provider numbers with Government Reimbursement Programs through fiscal intermediaries.
Seller is in compliance with the conditions of participation for the Government Reimbursement
Programs in all material respects. Except as described on Schedule 2.9, there are no
pending, or threatened Proceedings or investigations under the Government Reimbursement Programs
involving Seller. The cost reports of Seller, as applicable, for the Government Reimbursement
Programs referred to above, and for payment and reimbursement of any other cost report settlements,
required to be filed prior to the Effective Time, have been or will be properly filed and are or
will be complete and correct in all material respects. The cost reports required to be filed by
Seller do not claim, and Seller has not received any payment or reimbursement in excess of, the
amount provided by law or any applicable agreement, except where excess reimbursement was noted on
the cost report. Except as described on Schedule 2.9, there are no claims, actions or
appeals pending before any commission, board or agency, including any fiscal intermediary or
carrier, Governmental Authority or the Administrator of the Centers for Medicare and Medicaid
Services, with respect to any Government Reimbursement Program cost reports or claims filed on
behalf of Seller referred to above or any disallowances by any commission, board or agency in
connection with any such cost reports.

     (b) Neither Seller, nor to Seller’s Knowledge, any partner, member, director, officer or
employee of Seller, nor any agent acting on behalf of or for the benefit of any of the foregoing,
has directly or indirectly in connection with the Business or the Acquired Assets in violation of
any Legal Requirements: (i) offered or paid any remuneration, in cash or in kind, to, or made any
financial arrangements with, any past, present or potential customers, past or present suppliers,
patients, medical staff members, contractors or third party payors of Seller; (ii) given or agreed
to give, or is aware that there has been made or that there is any agreement to make, any gift or
gratuitous payment of any kind, nature or description (whether in money, property or services) to
any customer or potential customer, supplier or potential supplier, contractor, third party payor
or any other Person; (iii) made or agreed to make, or is aware that there has been made or that
there is any agreement to make, any contribution, payment or gift of funds or property to, or for
the private use of, any governmental official, employee or agent where either the contribution,
payment or gift or the purpose of such contribution, payment or gift is or was illegal under the
Legal Requirements of the United States or under the Legal Requirements of any state or any other
Governmental Authority having jurisdiction over such payment, contribution or gift;
(iv) established or maintained any unrecorded fund or asset for any purpose or made any misleading,
false or artificial entries on any of its books or records for any reason; or (v) made, or agreed
to make, or is aware that there has been made or that there is any agreement to make, any payment
to any Person with the intention or understanding that any part of such payment would be used for
any purpose other than that described on the documents supporting such payment.

     (c) Neither Seller nor any partner, member, director, officer or employee of Seller is a party
to any Contract (including any joint venture or consulting agreement) related to Seller, its
Business or the Acquired Assets with any physician, health care facility, hospital, nursing

- 11 -

 

facility, home health agency or other Person who is in a position to make or influence
referrals to or otherwise generate business for Seller with respect to the Hospital or the
Purchased Assets, to provide services, lease space, lease equipment or engage in any other venture
or activity, to the extent that any of the foregoing is prohibited by Legal Requirements.

     (d) The Hospital is fully accredited by The Joint Commission (“Joint Commission”), and Seller
has made available to Buyer true and complete copies of the most recent Joint Commission
accreditation survey report and deficiency list for the Hospital, if any, and the Hospital’s plan
of correction, if any.

     (e) Seller is in compliance with the Medicare Fraud and Abuse Amendments of 1977, as amended
by the Medicare Patient and Program Protection Act of 1987 (the “Anti-Kickback Statute”), federal
prohibitions on physician “self-referrals” (the “Stark Law”), the Health Insurance Portability and
Accountability Act of 1996 (“HIPAA”), the civil monetary penalties law, 42 U.S.C. § 1320a-7a(b)
(“CMP”), Federal False Claims Act, 42 U.S.C. §§ 3729 – 3733 (“FCA”), and Orders.

     2.10 No Violation of Law. Seller (a) is not in violation of any Legal Requirements
and (b) has not received any current written notice of any alleged violation or non-compliance with
any Legal Requirement.

     2.11 Legal Proceedings. Except as described on Schedule 2.11, there are no
Proceedings instituted or pending or threatened against Seller that challenge, or may have the
effect of preventing, delaying, making illegal or otherwise interfering with, the transactions
contemplated hereby, and there are no Orders outstanding or threatened against Seller that
challenge, or that may have the effect of preventing, delaying, making illegal or otherwise
interfering with, the transactions contemplated hereby. Except as described on
Schedule 2.11, Seller is not a party to any Proceedings, and Seller and the Acquired Assets
are not subject to any Orders. Seller has not received notice of any pending action, suit,
Proceeding or investigation by or before any court, arbitrator or Governmental Authority concerning
the Business or the affairs of Seller or to which the Acquired Assets are subject, and, to Seller’s
Knowledge, there is no basis for any such action. There is no action, suit or Proceeding or
investigation that is currently being threatened in writing against Seller or against any
stockholder, officer, director, manager, member or employee of Seller in relation to or otherwise
involving the Business, Acquired Assets or affairs of Seller.

     2.12 Fees and Commissions. Any fees associated with the retention of a financial
advisor of or other intermediary who has acted on behalf of Seller in connection with the
negotiation or consummation of this Agreement or the transactions contemplated thereby are the sole
and exclusive obligation of the Seller, including any broker’s, finder’s or originator’s fees or
commissions by reason of services rendered for or, at the instance of, Seller in connection with
this Agreement or the transactions contemplated hereby.

     2.13 Material Contracts. Schedule 2.13 lists all Material Contracts. Except
as described on Schedule 2.13, each Material Contract (a) has been entered into by Seller
in the normal course of its Business, and (b) is in full force and effect, and has not been amended
or modified except as described on Schedule 2.13. Seller is not currently in default in
any material

- 12 -

 

respect, nor has Seller received any written notice that it is in default, with respect to any
Material Contract, and no other party to any Material Contract is currently in default in any
material respect or has any defense, counterclaim or offset right. Seller has not assigned or
encumbered any such Material Contract in any manner.

     2.14 Insurance. Schedule 2.14 sets forth a true and complete list of all
insurance policies or self-insurance funds maintained by Seller covering the ownership and
operation of the Business and the Acquired Assets, indicating the types of insurance, policy
numbers, terms, identity of insurers and amounts and coverages (including applicable deductibles).
Seller has one or more “business interruption” insurance policies in customary form and amount
covering Business and the Acquired Assets (which coverage includes coverage from the date hereof
until the Closing Date), and the proceeds of such policies are assignable to Buyer as to the period
from the date hereof until the Closing Date if the Closing occurs as contemplated hereunder. All
of such policies are now and will be until the Closing in full force and effect on an occurrence
basis with no premium arrearages. Such policies of insurance shall not be assigned to Buyer as
part of the Acquired Assets and Buyer acknowledges that all of the coverages listed on
Schedule 2.14 with respect to the Purchased Assets will cease with respect to events
occurring after the Effective Time.

     2.15 Tax Matters.

     (a) For purposes of this Section 2.15, “Tax Returns” means all reports, estimates,
declaration of estimated Tax, information statements and returns relating to, or required to be
filed in connection with, any Taxes and any schedules attached to or amendments of (including
refund claims with respect to) any of the foregoing.

     (b) Except as described on Schedule 2.15 (i) all Tax Returns required to be filed by
or on behalf of Seller in respect of income, assets or other items relating to Seller, in all
cases, have been duly filed on a timely basis or within the applicable final extension periods
granted to it; (ii) such Tax Returns are true, complete and correct in all respects; and (iii) all
Taxes owed by Seller with respect to any taxable period or partial taxable period of Seller ending
prior to the Effective Time have been paid or will be timely paid by Seller.

     2.16 Environmental Matters. Attached hereto as Exhibit B is the original
environmental report prepared by Seller (the “Report”). Seller is in compliance with all terms and
conditions of all permits, licenses and authorizations, and is in compliance in all material
respects with all other Legal Requirements and regulations relating to the emission, discharge,
release or threatened release of any Hazardous Materials into air, surface water, groundwater or
lands (“Environmental Requirements”). No discharge or release of any Hazardous Material caused by
Seller has occurred on or otherwise affects any property owned or operated by the Seller that is
included within the Acquired Assets which violates Environmental Requirements.

     2.17 Absence of Certain Changes or Events.

     (a) Except as set forth in Schedule 2.17(a), since September 30, 2007, there has not
been any development (including consummation of the transactions contemplated hereby) or
threatened development of a nature which would be reasonably likely to cause any material

- 13 -

 

adverse change in the financial condition, net worth, assets, liabilities, personnel, or
operations (including any of the Seller’s or its Affiliate’s relationships with suppliers (other
than Buyer), employees and customers) of the Business or the ability of Seller to perform its
obligation under this Agreement and any related agreements (collectively, “Material Adverse
Effect”); provided, however, that none of the following shall in themselves constitute, and none of
the following shall be taken into account in determining whether there has been or will be a
Material Adverse Effect: (i) any change, effect or circumstance to the extent arising primarily by
reason of a deterioration in the financial markets, the general economy or the industries in which
the Seller operates; (ii) any change, effect or circumstance to the extent directly arising out of
action taken by Buyer or any of its Affiliates, the announcement of this transaction and the
consummation of the transactions contemplated hereby; (iii) any change, effect or circumstance to
the extent attributable primarily to any acts of war involving the United States or hostilities or
terrorist activity involving the United States, including without limitation, any continuation or
material worsening of hostilities involving the combat of terrorism or other national security
issues involving the United States; (iv) general economic, regulatory or political conditions or
changes, (v) changes in Legal Requirements or GAAP after the Execution Date; (vi) compliance with
the terms of this Agreement; or (vii) an earthquake or other natural disaster, subject to the
provisions of Section 4.5.

     (b) Except as specifically set forth in Schedule 2.17(b), and except as expressly
authorized by this Agreement to accomplish the transactions contemplated hereby, since January 1,
2008, Seller has conducted (and from the date hereof through the Effective Time, will continue to
conduct) the Business and its operations only in the ordinary course in all material respects.
Without limiting the generality of the foregoing, since September 30, 2007, and, except as set
forth on Schedule 2.17(b) and, except for transactions required to effect this Agreement,
Seller has not (and from the Execution Date through the Effective Time, will not):

     (i) created or suffered to exist any liens, encumbrances or other restrictions with
respect to any of the Acquired Assets, except for the Permitted Real Property Encumbrances;

     (ii) sold, leased to others, licensed to others, disposed of, or otherwise transferred
any of the material assets or properties of the Business, except for (i) sales of inventory
in the usual and ordinary course of the Business, (ii) sales of old or obsolete equipment
that has been replaced with equipment that is functionally equivalent and (iii) sales of
other obsolete equipment with an aggregate value of less than $100,000;

     (iii) suffered any material loss, or material interruption in use, of any material
asset or property of the Business (whether or not covered by insurance) on account of fire,
flood, riot, strike or other hazard or act of God in excess of $100,000;

     (iv) purchased, called, redeemed or otherwise acquired (other than for cash) or
declared or paid any dividends or other distributions (other than cash) on or with respect
to, any equity interest in Seller or any of its Affiliates;

     (v) (A) increased the rate or terms of compensation (including termination and
severance pay), commission, bonus or other direct or indirect remuneration (or the rate

- 14 -

 

thereof) payable or to become payable to any of Seller’s employees, officers, directors
or persons otherwise serving in such capacities, other than regularly scheduled increases in
base salary in the ordinary course and consistent with past practice in all material
respects; or (B) adopted, amended or terminated any Employee Benefit Plan, unless such
adoption, amendment or termination affects all Affiliates of MedCath that own or operate
hospitals, or entered into any employment, consulting, severance or termination agreement;

     (vi) waived any rights relating to the Business or arising under or in connection with
any of the Acquired Assets, individually or in the aggregate in excess of $100,000;

     (vii) acquired any assets or properties individually or in the aggregate in excess of
$100,000 other than in the ordinary course and consistent with past practice;

     (viii) entered into any merger, consolidation, recapitalization or other business
combination or reorganization;

     (ix) made any loans, advances or capital contributions to or investments in any Person,
other than (A) loans and advances to employees in amounts that do not individually exceed
$10,000 or in the aggregate exceed $50,000 and (B) loans and advances to any holders of an
equity interest in Seller;

     (x) induced any employee receiving annual compensation in excess of $50,000, to leave
his or her employment, or acted to otherwise adversely affect the relations with any such
employee receiving annual compensation in excess of $50,000;

     (xi) delayed payment of payables, changed credit practices or done anything to
materially and adversely affect the relationship of the Business with any customers or
supplier that is material to the Business (other than Buyer);

     (xii) failed to replenish inventories and supplies in the ordinary course and
consistent in all material respect with prior practice, or made any purchase commitment
materially in excess of the usual requirements of the Business or at any price materially in
excess of the then-current market price or upon terms and conditions more onerous than those
usual and customary in the industry or made any material change in its selling, pricing,
advertising or personnel practices inconsistent with its prior practice;

     (xiii) commenced or terminated any line of business;

     (xiv) made any change in its general pricing practices or policies or any change in its
credit or allowance practices or policies other than in the ordinary course;

     (xv) received written notice from any customer or supplier representing during the last
fiscal year sales or purchases of $100,000 or more that such customer or supplier has
ceased, may cease or will cease to do business with it;

- 15 -

 

     (xvi) entered into any transaction, agreement, contract or understanding with any
Person (other than Buyer) affecting the Business or altered the terms of any transaction,
agreement, contract or understanding with any Person (other than Buyer) affecting the
Business which involves expenditure in excess of $100,000;

     (xvii) without limiting the foregoing, entered into any material transaction resulting
in a liability or expenditure in excess of $100,000, other than in the ordinary course;

     (xviii) entered into any material amendment, modification, termination (partial or
complete) or granted any material waiver under or given any material consent with respect to
any Contract that is required to be disclosed in the Schedules to this Agreement;

     (xix) made any change in any method of accounting or accounting practice that applied
only to Seller and not to MedCath and its subsidiaries on a consolidated basis;

     (xx) made or deferred any capital expenditure in each case in excess of $100,000
individually and $250,000 in the aggregate; and

     (xxi) except for this Agreement, entered into any oral or written agreement, contract,
commitment, arrangement or understanding with respect to any of the matters described in
this Section 2.17(b).

     2.18 Employees.

     (a) Schedule 2.18(a) lists the employees of Seller and their current rates of
compensation, dates of hire, status (i.e., exempt or non-exempt) and eligibility for, and
participation in, Employee Benefit Plans. Except as described on Schedule 2.18(a),
(i) there are no collective agreements or bargaining relationships or other contracts or
understandings with any labor organization with respect to Seller’s employees, (ii) the Seller has
no Knowledge of any organizational effort presently being made or threatened by or on behalf of any
labor union with respect to employees of the Seller, and to the Seller’s Knowledge no such efforts
have occurred within the past three years, (iii) there is no worker’s compensation liability,
experience or matter outside the Ordinary Course of Business, (iv) there are no strikes, slowdowns,
work stoppages, material grievances, material unfair labor practices claims or other material
employee or labor disputes currently pending or threatened against or involving the Seller and none
has occurred within the last three years, (v) the Seller has not engaged in any unfair labor
practices within the meaning of the National Labor Relations Act, (vi) during the three year period
preceding the Closing Date, the Seller has not implemented any layoffs of employees that could
implicate the Worker Adjustment and Retraining Notification Act, 29 U.S. Stat. § 2101 et seq. (the
"WARN Act”), (vii) there are no pending or threatened in writing complaints or charges before any
Governmental Authority regarding employment discrimination, safety or other employment-related
charges or complaints, wage and hour claims, unemployment compensation claims, worker’s
compensation claims or the like involving any current or former employee of Seller, (viii) Seller
is in compliance in all material respects with all Legal Requirements and Contracts respecting
employment and employment practices, labor relations, terms and

- 16 -

 

conditions of employment and wages and hours and (ix) Buyer will not be subject to any claim
or liability for severance pay as a result of the consummation of the transactions contemplated by
this Agreement as long as Buyer fulfills its obligations under the term of this Agreement.

     (b) All Employee Benefit Plans maintained by the Seller or to which the Seller is obligated to
contribute, are listed on Schedule 2.18(b) hereto. With respect to the Employee Benefit
Plans:

     (i) a copy of each such Employee Benefit Plans has been made available to the Buyer
and/or its agents;

     (ii) all such Employee Benefit Plans have been maintained, funded and administered in
compliance in all material respects with all applicable Legal Requirements, including ERISA
and the Code;

     (iii) no Employee Benefit Plan is or has within the last three years been subject to
the minimum funding requirements of Section 412 or 430 of the Code or Title IV of ERISA;

     (iv) the Seller does not have any obligation to contribute to any “multiemployer plan”
within the meaning of Section 3(37) of ERISA;

     (v) each Employee Benefit Plan intended to qualify under Section 401(a) of the Code has
received a favorable determination letter or is entitled to rely on an opinion letter from
the Internal Revenue Service that such Employee Benefit Plan is a “qualified plan” under
Section 401(a) of the Code, the related trust is exempt from tax under Section 501(a) of the
Code, and no facts or circumstances exist that would be reasonably likely to jeopardize the
qualification of such Employee Benefit Plan; and

     (vi) with respect to the Employee Benefit Plans, all required contributions have been
made or properly accrued on the Seller’s financial statements.

     2.19 Financial Information.

     (a) Schedule 2.19 hereto contains the following financial statements and financial
information (collectively, the “Historical Financial Information”): (i) audited balance sheets and
income statements of the Seller for the twelve-month periods ended September 30, 2007 and September
30, 2006; (ii) unaudited balance sheet and income statement of the Seller dated for the period from
October 1, 2007 through December 31, 2007; and (iii) the most recently available unaudited balance
sheet and income statement of Seller.

     The financial statements included in the Historical Financial Information have been prepared
in accordance with GAAP, applied on a consistent basis throughout the periods indicated provided
that the unaudited statements are not footnoted and are subject to customary year end adjustments,
and Seller has not changed any accounting policy or methodology throughout all periods presented
that applied only to Seller and not to MedCath and its subsidiaries on a consolidated basis. The
balance sheets contained in the Historical Financial Information present fairly in all material
respects the financial condition of Seller as of the dates

- 17 -

 

indicated thereon, and the income statements contained in the Historical Financial Information
present fairly in all material respects the results of operations of Seller for the periods covered
thereby.

     (b) Except for (i) liabilities that are disclosed in this Agreement, the Historical Financial
Statements, Contracts entered into in connection herewith and schedules and exhibits hereto and
thereto, and (ii) liabilities that were incurred after February 29, 2008, in the ordinary course of
business, there are no material liabilities of any nature of Seller relating to the Hospital or the
Acquired Assets and Assumed Liabilities.

     2.20 Intellectual Property.

     (a) Except as described on Schedule 2.20, there is no unauthorized use, disclosure,
infringement or misappropriation of any intellectual property rights of Seller, any trade secret of
Seller, or any intellectual property right of any third party to the extent licensed by or through
Seller, including any employee or former employee of Seller, relating in any way to any of the
Acquired Assets. There are no royalties, fees or other payments payable by Seller to any Person by
reason of the ownership, use, sale or disposition of intellectual property related to any of the
Acquired Assets except as set forth in the Contracts.

     (b) Except as described on Schedule 2.20, Seller is not nor will be as a result of the
execution and delivery of this Agreement or any of the documents described herein or the
performance of its obligations under this Agreement or any of the documents described herein, in
breach of any license, sublicense or other Contract relating to the intellectual property included
in the Acquired Assets, provided that no representation is made regarding the absence of a breach
due to the failure to obtain any required third party consent to the assignment of any Contract.

     (c) Except as described on Schedule 2.20, Seller has no patents, registered
trademarks, registered service marks or registered copyrights related to any of the Acquired
Assets, and Seller is not infringing upon any patents, trademarks, service marks, copyrights or in
violation of any trade secret or other proprietary right of any third party related to any of the
Acquired Assets. Seller has not brought any Proceeding against any third party for infringement of
intellectual property or breach of any license or Contract involving intellectual property related
to any of the Acquired Assets.

     2.21 Completeness of Disclosure. No representation or warranty by Seller in this
Agreement or statement made by Seller in any schedule to this Agreement, or any certificate or
other document furnished or to be furnished to Buyer pursuant hereto, or in connection with the
negotiation, execution or performance of this Agreement, contains or will at the Closing contain
any untrue statement of a material fact or omits or will omit to state a material fact required to
be stated herein or thereon or necessary to make any statement herein or therein not misleading in
any material respect.

     EXCEPT FOR THE EXPRESS REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS ARTICLE 2, THE
ACQUIRED ASSETS ARE BEING SOLD TO BUYER “AS IS, WHERE IS, AND WITH ALL FAULTS”, AND SELLER
EXPRESSLY

- 18 -

 

DISCLAIMS ANY AND ALL OTHER REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS OR IMPLIED,
INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF BUYER

     As of the Execution Date and again as of the Closing Date, Buyer represents and warrants to
Seller that, except as contained in the disclosure Schedules attached hereto and incorporated
herein:

     3.1 Organization, Corporate Power and Authority.

     (a) Buyer is an Ohio public benefit corporation duly organized, validly existing and in good
standing under the laws of the State of Ohio.

     (b) Buyer has full corporate power and authority to execute, deliver and perform the corporate
obligations and covenants contained in this Agreement and Buyer’s Closing Documents and to carry
out the transactions contemplated hereby and thereby. The execution and delivery of this Agreement
and Buyer’s Closing Documents by Buyer and the consummation of the transactions contemplated hereby
and thereby have been duly authorized by all necessary action on the part of Buyer. This Agreement
constitutes the legal, valid, and binding obligation of Buyer, enforceable in accordance with its
terms, subject to applicable Exceptions. Each of Buyer’s Closing Documents, when duly executed and
delivered by Buyer and the other Parties thereto, will constitute the legal, valid and binding
obligation of Buyer enforceable in accordance with its respective terms, subject to applicable
Exceptions.

     3.2 No Breach. Neither the execution and delivery of this Agreement and related
agreements contemplated herein by Buyer nor the consummation or performance of the transactions
contemplated hereby or in the Buyer’s Closing Documents will, directly or indirectly (with or
without notice, lapse of time, or both): (i) conflict with or result in the breach or violation of
the governing documents of or resolutions adopted by Buyer; (ii) conflict with or result in the
breach or violation of any provision of any Order of any Governmental Authority, in either such
case, to which Buyer, or any of the Acquired Assets, are bound, or cause any acceleration thereof;
or (iii) contravene, conflict with, or result in a violation in any Legal Requirements. Except for
the other approvals and consents described on Schedule 3.2, Buyer is not and will not be
required to give any notice to or obtain any consent from any Governmental Authority in connection
with the execution and delivery of this Agreement or the consummation of the transactions
contemplated hereby.

     3.3 Legal Proceedings. Except as provided in Schedule 3.3, there are no
Proceedings instituted, pending or threatened against Buyer that challenge, or may have the effect
of preventing, delaying, making illegal or otherwise interfering with, the transactions
contemplated hereby, and there are no Orders outstanding or threatened against Buyer that
challenge, or that may have the effect of preventing, delaying, making illegal or otherwise
interfering with, the transactions contemplated hereby.

- 19 -

 

     3.4 Fees and Commissions. No finder, broker, agent, financial advisor or other
intermediary has acted on behalf of Buyer in connection with the negotiation or consummation of
this Agreement or the transactions contemplated thereby, and Buyer has not directly or indirectly
agreed to pay or become liable to pay any broker’s, finder’s, or originator’s fees or commissions
by reason of services alleged to have been rendered for, or at the instance of, Buyer in connection
with this Agreement or the transactions contemplated hereby.

     3.5 Funding of Purchase Price. The Buyer has sufficient cash available to enable it
to fulfill its obligations hereunder and to make payment of all amounts to be paid by it hereunder
on the Closing Date, it being acknowledged that there is no financing contingency as a condition to
Buyer’s obligation to complete this transaction.

ARTICLE 4

CONDITIONS TO THE OBLIGATIONS OF BUYER

     The obligations of Buyer to consummate the purchase of the Acquired Assets and any other
transaction contemplated by this Agreement are subject to the satisfaction, on or before the
Closing Date, of the following conditions:

     4.1 Representations and Warranties to be True and Correct. The representations and
warranties of Seller contained in ARTICLE 2 shall be true, complete and correct in all material
respects on and as of the Execution Date and the Closing Date with the same effect as though such
representations and warranties had been made on and as of such date, and an officer of Seller shall
have certified to such effect to Buyer in writing. Notwithstanding the foregoing, Buyer
acknowledges and agrees that, except for the failure or alleged failure of the representations and
warranties set forth in Sections 2.1(b), 2.3 and 2.10 or the identification
of a Material Structural Problem or Material Environmental Problem (as such terms are defined in
the Escrow Agreement), Buyer will not assert the breach or alleged breach of any representation or
warranty made by the Seller as a basis for not consummating the transactions contemplated by this
Agreement and the sole and exclusive remedy of the Buyer for the breach of any such representation
and warranty is indemnification as and to the extent set forth in ARTICLE 8.

     4.2 Covenants. Seller shall have performed and complied with all of its covenants
hereunder through Closing.

     4.3 No Action or Proceeding. No Order of any Governmental Authority restraining,
enjoining or otherwise preventing or delaying the consummation of this Agreement or the
transactions contemplated hereby shall be outstanding, and no Proceedings or investigations by or
before, or otherwise involving, any Governmental Authority shall be threatened or pending against
Seller or Buyer which seeks to enjoin or prevent the consummation of the transactions contemplated
under this Agreement or which seeks damages in connection with the transactions contemplated
hereby.

     4.4 Seller’s Closing Deliverables. Buyer and its counsel shall have received executed
copies of the following documents (the “Seller’s Closing Documents”):

- 20 -

 

     (a) Bill of Sale and Assignment. A bill of sale and assignment, substantially in the
form attached hereto as Exhibit C, executed by Seller conveying to Buyer good and
marketable title to all tangible assets, including Personal Property, which are a part of the
Acquired Assets and good and marketable title to all intangible assets which are a part of the
Acquired Assets, free and clear of all encumbrances (other than Permitted Real Property
Encumbrances and those of lessors under Personal Property Leases which are operating leases under
GAAP).

     (b) Assignment and Assumption Agreement. Assignment and assumption agreement,
substantially in the form attached hereto as Exhibit D (the “Assignment and Assumption
Agreement”) executed by Seller: (i) conveying to Buyer all of Seller’s right, title and interest
in, to and under the Assumed Contracts and, by one or more separate instruments, the Real Property
Leases and Licenses, and (ii) pursuant to which Buyer shall assume the future payment and
performance of the Assumed Liabilities.

     (c) Deed. For each interest of Seller in the Owned Real Property, as applicable, a
recordable limited warranty deed (a “Deed”) in the form attached hereto as Exhibit E
executed by Seller.

     (d) Authorizing Resolutions. Copies of duly adopted resolutions of the board of
directors of Seller, authorizing and approving Seller’s performance of the transactions
contemplated hereby and the execution and delivery of this Agreement and the Seller’s Closing
Documents, certified by the appropriate officer or officers of Seller as true and in full force and
effect as of the Closing.

     (e) Certificates. Receipt of certificates executed by Seller and dated as of the
Closing Date and reasonably satisfactory in form and substance to Buyer, certifying that (i) each
of the representations and warranties of Seller contained herein is true and correct on and as of
the Closing Date, and (ii) Seller shall have performed and complied with all agreements,
obligations, covenants and conditions required to be performed or complied with by them pursuant
hereto on or prior to the Closing Date, except as may have been waived in writing by Buyer.

     (f) Secretary’s Certificate. A certificate of the Secretary or an Assistant Secretary
of Seller dated as of the Closing Date and certifying: (i) that attached thereto is a true and
complete copy of all resolutions adopted by the members of Seller authorizing the execution,
delivery, and performance of this Agreement and all transactions contemplated by this Agreement and
that all such resolutions are in full force and effect and are all the resolutions adopted in
connection with the transactions contemplated by this Agreement; and (ii) to the incumbency and
specimen signature of each officer of Seller executing this Agreement or the other documents to be
delivered by Seller pursuant to this Agreement, and a certification by another officer of Seller as
to the incumbency and signature of the officer signing the certificate referred to in this
Section 4.4(f).

     (g) Transition Services Agreement. To the extent determined necessary by good faith
negotiation by and between Buyer and MedCath, MedCath shall have executed and delivered a
Transition Services Agreement with terms and conditions substantially similar to those set forth in
the form attached hereto as Exhibit F.

- 21 -

 

     (h) Real Property Transfers. Such documents as the Title Company reasonably and
customarily requires in connection with the issuance of a standard title insurance policy,
including a standard title insurance agreement or affidavit necessary to cause the Title Company to
delete all standard printed title exceptions from the Title Policy certifying, among other things,
as to the absence of and providing for indemnity by Seller from mechanic’s and materialmen’s liens,
tenants and parties in possession, Seller’s authority documents and Seller’s legal existence and
good standing certificates.

     (i) FIRPTA Certificate. A FIRPTA certificate, executed by Seller certifying Seller’s
U.S. taxpayer identification number and that Seller is not a foreign Person, within the meaning of
Section 1445 of the Code.

     (j) Certificate of Good Standing. A certificate of good standing of Buyer from the
Secretary of State of the State of Ohio dated no earlier than ten (10) days prior to the Closing.

     4.5 No Material Casualty. Between the Execution Date and the Effective Time, no
Material Casualty shall have occurred. A “Material Casualty” shall mean damage or destruction of
any part of the Acquired Assets by fire or the elements or by any other cause and the cost to
repair such damage is reasonably likely to exceed Two Million Seven Hundred Fifty Thousand Dollars
($2,750,000.00). In the event of a Material Casualty, Seller shall within fifteen (15) business
days after such Material Casualty provide written notice thereof to Buyer. Such notice shall
include copies of all insurance policies then in force relating to the Acquired Assets covering
such Material Casualty and, Seller’s initial good faith estimate of the cost to repair such damage
or destruction (“Cost Estimate”). Buyer may, by written notice to Seller within twenty (20) days
after Buyer’s receipt of notice of the Material Casualty, elect in writing to terminate this
Agreement. Should Buyer terminate this Agreement in accordance with the provisions of this
Section 4.5, this Agreement shall be terminated. If any part of the Acquired Assets is
damaged or destroyed prior to the Closing Date but this Agreement cannot be terminated or is not
terminated by Buyer, this Agreement shall not be affected and the parties shall not be excused from
performance hereunder, but, as of the Effective Time, at Buyer’s request, Seller shall assign to
Buyer all of its right, title and interest in and to the proceeds of insurance insuring against the
loss and Seller’s interest in sums payable thereunder or, to the extent that such proceeds are less
than the Cost Estimate, make payment to Buyer in amount that together with such proceeds equals the
Cost Estimate.

ARTICLE 5

CONDITIONS TO THE OBLIGATIONS OF SELLER

     The obligations of Seller to consummate the sale of the Acquired Assets and any other
transaction contemplated by this Agreement are subject to the satisfaction, on or before the
Closing Date, of the following conditions.

     5.1 Representations and Warranties to be True and Correct. The representations and
warranties of Buyer contained in ARTICLE 3 shall be true, complete and correct in all material
respects (except to the extent qualified by materiality or Material Adverse Effect, in which case
they shall be true and correct in all respects) on and as of the Execution Date and the

- 22 -

 

Closing Date, with the same effect as though such representations and warranties had been made
on and as of such date, and an officer of Buyer shall have certified to such effect to Seller in
writing. Notwithstanding the foregoing, Seller acknowledges and agrees that Seller will not assert
the breach or alleged breach of any representation or warranty made by Buyer as a basis for not
consummating the transactions contemplated by this Agreement and the sole and exclusive remedy of
Seller for the breach of any such representation and warranty is indemnification as and to the
extent set forth in ARTICLE 8.

     5.2 Performance. Buyer shall have performed and complied in all material respects
with all of its covenants hereunder through Closing.

     5.3 No Action or Proceeding. No Order of any Governmental Authority restraining,
enjoining or otherwise preventing or delaying the consummation of this Agreement or the
transactions contemplated hereby shall be outstanding, and no Proceeding or investigations by or
before, or otherwise involving, any Governmental Authority shall be threatened or pending against
Seller or Buyer which seeks to enjoin or prevent the consummation of the transactions contemplated
under this Agreement or which seeks material damages in connection with the transactions
contemplated hereby.

     5.4 Buyer’s Closing Deliverables. Seller and their counsel shall have received
executed copies of the following documents (the “Buyer’s Closing Documents”):

     (a) Assignment and Assumption Agreement. The Assignment and Assumption Agreement
executed by Buyer, pursuant to which Buyer shall assume the future payment and performance of the
Assumed Liabilities.

     (b) Certificates. Receipt of a certificate executed by Buyer, dated as of the Closing
Date and reasonably satisfactory in form and substance to Seller, certifying that (i) each of the
representations and warranties of Buyer contained herein is true and correct in all material
respects on and as of the Closing Date, and (ii) Buyer has performed and complied in all material
respects with all agreements, obligations, covenants, and conditions required to be performed or
complied with by them pursuant hereto on or prior to the Closing Date, except as may have been
waived in writing by Seller.

     (c) Certificate of Good Standing. A certificate of good standing of Buyer from the
Secretary of State of the State of Ohio dated no earlier than ten (10) days prior to the Closing.

     (d) Secretary’s Certificate. A certificate of the Secretary or an Assistant Secretary
of Buyer dated as of the Closing Date and certifying: (i) that attached thereto is a true and
complete copy of all resolutions adopted by the members of Buyer authorizing the execution,
delivery, and performance of this Agreement and all transactions contemplated by this Agreement and
that all such resolutions are in full force and effect and are all the resolutions adopted in
connection with the transactions contemplated by this Agreement; and (ii) to the incumbency and
specimen signature of each officer of Buyer executing this Agreement or the other documents to be
delivered by Buyer pursuant to this Agreement, and a certification by another officer of Buyer as
to the incumbency and signature of the officer signing the certificate referred to in this
Section 5.4(d).

- 23 -

 

     (e) Transition Services Agreement. To the extent determined necessary by good faith
negotiation by and between Buyer and MedCath, Buyer shall have executed and delivered a Transition
Services Agreement with terms and conditions substantially similar to those set forth in the form
attached hereto as Exhibit F.

ARTICLE 6

ADDITIONAL AGREEMENTS

     6.1 Retention and Access to Records. After the Closing Date, Buyer shall retain the
Transferred Records for a period consistent with Buyer’s record retention policies and practices,
but in any event for at least the minimum period for which such Transferred Records are required to
be retained under applicable Legal Requirements. Buyer also shall provide Seller and MedCath and
their representatives reasonable access thereto, during normal business hours and on reasonable
prior written notice, to enable them to prepare financial statements, tax returns, respond to tax
audits or any other reasonable business purpose. Seller shall retain copies of all records that
may pertain to any Excluded Liabilities or Excluded Assets. After the Closing Date, Seller shall
provide Buyer and its representatives reasonable access to Excluded Records during normal business
hours and on reasonable prior written notice, for any reasonable business purpose.

     6.2 Access to Acquired Assets; Contracts.

     (a) Between the Execution Date and the Closing Date, Seller shall afford to the authorized
representatives and agents of Buyer reasonable access to and the right to inspect the plants,
properties, books and records of Seller relating to the Business and the Acquired Assets, and will
furnish Buyer with such additional financial and operating data and other information as to the
Business and the Acquired Assets as Buyer may from time to time reasonably request. Buyer’s right
of access and inspection shall be made in such a manner as not to interfere unreasonably with the
operation of Seller’s Business or Seller’s use of the Acquired Assets. Buyer may not conduct any
borings, drilling or other non-destructive testing without first requesting and obtaining Seller’s
prior written consent, which shall not be unreasonably withheld. Buyer shall keep all information
and data received or discovered in connection with the due diligence inspections of the Acquired
Assets strictly confidential, sharing all such information only with its consultants, its lenders,
and any potential equity investors in the Buyer entity. Buyer agrees that it will restore the
Acquired Assets to its condition prior to conducting any tests or inspections. Buyer will
indemnify and hold Seller harmless from any and all liability for property damage and/or personal
injuries arising out of or related in any way to the activities of Buyer or its contractors,
agents, or employees in their conduct of any such investigations and tests.

     (b) This Agreement shall not constitute an attempt to assign any Acquired Asset or assume any
Assumed Liability, if the attempted assignment or assumption of same, as a result of the absence of
a consent or authorization of a third party, would constitute a breach or default under any lease,
agreement or commitment or would in any way adversely affect the rights, or increase the
obligations, of Buyer or Seller with respect thereto. Except as otherwise agreed to by the
Parties, Buyer and Seller shall cooperate in good faith for obtaining any consent or

- 24 -

 

authorization of a third party necessary for the assignment of any Acquired Asset to Buyer or the
assumption by Buyer of any Assumed Liability. With respect to any Acquired Asset, if Seller fails
to obtain the consent or authorization necessary for the assignment of such Acquired Asset prior to
Closing, then Buyer may, at its option and expense, require Seller to enter into such arrangement
(including sublease, agency, pass through, indemnity or payment arrangement) as reasonably
necessary to provide Buyer with the benefits of such Acquired Asset. With respect to any Assumed
Liability, Buyer agrees to cooperate with Seller to the extent reasonably necessary to relieve
Seller from the obligations of such Assumed Liability.

     (c) As of the Execution Date, Buyer and Seller have not fully identified the Assumed Contracts
referenced in Section 1.1(d) or the Excluded Contracts, other than those Excluded Contracts
described in Section 1.2(a) or 6.2(e). Schedule 6.2(c)(i) contains
Seller’s preliminary, good faith determination of those Contracts in effect as of the Execution
Date (collectively, the “Existing Contracts”), and Schedule 6.2(c)(ii) contains the
preliminary determination of Buyer as to whether it will assume or require termination of such
Existing Contracts (each a “Buyer Determined Contract”). Contingent upon the Closing, Seller
agrees to terminate each such Buyer Determined Contract that Buyer has designated on
Schedule 6.2(c)(ii) for termination if such Contract is permitted to be terminated by
Seller in accordance with its terms , and, subject to Section 6.2(e), each such Buyer
Determined Contract shall be an Excluded Contract. Contingent upon the Closing, Seller agrees to
assign to Buyer all other Buyer Determined Contracts and each such Buyer Determined Contract shall
be an Assumed Contract.

     (d) Between the Execution Date and the Closing Date, Buyer and Seller shall work in good faith
to (i) identify any Contracts identified by Seller on Schedule 6.2(c)(i) as an Existing
Contract for which Buyer has not reached a determination as to whether it will assume or seek
termination of such Existing Contract on Schedule 6.2(c)(ii), (ii) identify any other
Contract that, despite Buyer or Seller’s good faith effort, as the case may be, was not included on
Schedule 6.2(c)(i) or Schedule 6.2(c)(ii) as of the Execution Date (each a “Buyer
Undetermined Contract”) or (iii) any Contract that Buyer or Seller determines was erroneously
included preliminarily on Schedule 6.2(c)(i) or Schedule 6.2(c)(ii) as of the
Execution Date . Upon written request by Buyer, Seller agrees to terminate, contingent upon the
Closing, any such Buyer Undetermined Contract if such Contract is permitted to be terminated by
Seller in accordance with its terms ,. Subject to the provisions of Section 6.2(e), each
Buyer Undetermined Contract that is terminated pursuant to this Section 6.2(d) shall be an
Excluded Contract. Each Buyer Undetermined Contract that is not terminated in accordance with this
Section 6.2(d) shall be an Assumed Contract.

     (e) With respect to the termination of any Contract by Seller pursuant to this
Section 6.2, Seller shall be entitled to pursue such terminations in a manner that will not
result in Seller incurring any losses, cost or expense relating to such termination if the Closing
does not occur. Buyer acknowledges and agrees that, with respect to any Contract for which it has
sought termination pursuant to this Section 6.2 or for any other Contract which Buyer does
not indicate is to terminated or assumed, it shall indemnify and hold Seller harmless against any
cost, expense or other Loss arising from such Contract from and after the Effective Time and from
any cost, expense or other Loss arising from either the termination of such Contract or the
failure to obtain a third party consent to the assignment of such Contract to Buyer .
Notwithstanding the foregoing, Seller acknowledges and agrees that, in no circumstance, shall

 - 25 - 

 

Buyer have any liability to Seller if Seller may terminate such Contract upon 30 days or less
written notice without cost or penalty to Seller.

     (f) Notwithstanding the foregoing, as of the Execution Date, all Contracts which involve
Seller’s licensing or use of software shall be deemed to be Excluded Contracts.   Between the
Execution Date and the Closing Date, the parties shall prepare a list of Seller’s software
Contracts which Buyer desires to assume. The parties shall cooperate in good faith to seek to
obtain any needed third party consents to such software contract assignments to Buyer, provided
that Seller shall not be obligated to incur any cost or expense in order to obtain such consents. 
If any such required consents to software contract assignments are obtained, then such Contracts
shall thereafter be Assumed Contracts. The schedules which are intended to identify software
Contracts as Assumed Contracts or Excluded Contracts shall be finalized by Seller based upon the
terms of this Section 6.2(f).

     6.3 Misdirected Payments. Seller shall promptly remit to Buyer any monies received by
Seller after Closing constituting or in respect of the Acquired Assets or Assumed Liabilities or
Buyer’s operation of the Business on or following the Effective Time. Buyer shall promptly remit
to Seller any monies received by Buyer after Closing constituting or in respect of the Excluded
Assets or Excluded Liabilities or Seller’s operation of the Business prior to the Effective Time.

     6.4 Cooperation on Tax Matters. Following the Closing, the Parties shall reasonably
cooperate with each other and shall make available to the other, as reasonably requested and at the
expense of the requesting Party (but including only out-of-pocket expenses to third parties,
photocopying and delivery costs and not the costs incurred by any Party for the wages or other
benefits paid to its officers, directors or employees), to any Tax authority, all information,
records or documents relating to Tax liabilities or potential Tax liabilities, if any, of Seller
for all periods on or prior to the Closing and any information which is relevant to determining the
amount payable under this Agreement, and shall preserve all such information, records and documents
(to the extent a part of the Acquired Assets delivered to Buyer at Closing) until the expiration of
any applicable statute of limitations or extensions thereof. Seller shall make available to Buyer
the records of individual wages of all employees, as well as copies of state unemployment Tax
returns, to the extent reasonably necessary for Buyer to verify future unemployment Tax rates and
to calculate the correct taxable payroll for the remainder of the calendar year in which the
transaction occurs. Seller shall file terminating Forms W-2 and Forms 1099 with respect to all
periods ending prior to the Closing Date, as appropriate.

     6.5 Third Party Litigation Cooperation. Seller, on the one hand, and Buyer, on the
other hand, shall cooperate with the other, at the requesting Party’s expense (but including only
direct out-of-pocket expenses to third parties, photocopying and delivery costs, and not the
indirect costs incurred by any Party, such as the wages or other benefits paid to its officers,
directors or employees), in furnishing reasonably available information, testimony and other
assistance in connection with any actions, Tax or cost report audits, Proceedings, arrangements or
disputes involving any of the Parties hereto (other than in connection with disputes between the
Parties hereto) and relating to the Acquired Assets, the Excluded Assets, Excluded Liabilities or
Assumed Liabilities or the transactions contemplated hereby, including arranging discussions

 - 26 - 

 

with, and the calling as witnesses of, officers, directors, employees, agents and
representatives of any Party.

     6.6 Confidentiality; Publicity.

     (a) All information, instruments, documents and details concerning the respective Businesses
of Buyer and Seller prior to the Closing are strictly confidential, and Seller and Buyer covenant
and agree that they will not, nor will they allow any of their respective officers, directors,
employees, attorneys or agents (including professional advisors) to, reproduce, distribute or
disclose any matters relating to the business of the other prior to the Closing or relating to the
proposed transaction, this Agreement, its negotiation, terms, provisions or conditions, including
the Purchase Price (collectively, the “Confidential Information”), except for disclosure to their
respective professional advisors (who shall be similarly bound) as reasonably necessary to effect
the transactions contemplated hereby and in a manner consistent with the provisions of this
Agreement.

     (b) Notwithstanding the foregoing, (i) nothing contained in this Section 6.5 shall
prohibit either Buyer or Seller from disclosing the transactions contemplated hereby to
Governmental Authorities to the extent reasonably necessary to obtain the Licenses, participations
and accreditations contemplated hereby or any other Governmental Authority approvals as may be
required for the transactions contemplated hereby; (ii) Buyer and Seller shall be entitled to
disclose to third parties such information regarding the transactions contemplated hereby as is
necessary to obtain such third parties’ consents to the assignment of any Assumed Contract; (iii)
each Party shall be entitled to disclose any information relating to a breach by another Party of
any of its obligations under this Agreement, but only in connection with a Proceeding as described
on Section 9.14 or Section 9.18 and (iv) disclosures required by any Legal
Requirements are permitted.

     (c) Without limiting the generality of the foregoing, except as specifically permitted by this
Section 6.6 or as required by any Legal Requirement, no public announcement or other
disclosure of the proposed sale or acquisition of the Acquired Assets or any Confidential
Information shall be made by or on behalf of either Buyer or Seller without the prior written
consent of the other Party and such other Party’s prior approval of the form and content of the
same, which consent and approval shall not be unreasonably withheld or delayed.

     (d) Except as specifically permitted by this Section 6.6, each Party shall keep all
Confidential Information obtained from any other Party either before or after the date of this
Agreement confidential, and no Party shall directly or indirectly, use, transfer, distribute,
disclose or reveal such information to, nor produce copies of any such written information for, any
Person outside its management group or its professional advisors without the prior written consent
of the other Parties, unless the disclosing Party is compelled or required to disclose such
information by judicial or administrative process or by any other Legal Requirements (including
applicable securities laws). If the sale contemplated by this Agreement should fail to close for
any reason, each Party shall return to the other or, in the case of copies, destroy as soon as
possible all originals and copies of written information provided to such Party by or on behalf of
such other Parties as well as all summaries, analyses, notes, and other embodiments of such
information (except an attorneys’ archival copy for records purposes only), and none of such

 - 27 - 

 

information shall be used by any Party, or its employees, agents or representatives, in the
business operations of any Person.

     (e) Notwithstanding the foregoing, each Party’s obligations under this Section 6.6
shall not apply to any information or document which is or becomes available to the public (other
than as a result of a disclosure in violation of any obligation or agreement) or becomes available
to the Party on a non-confidential basis from a source other than another Party or its officers,
directors, employees or agents. The Parties’ obligations under this Section 6.6 shall
survive for two (2) years after the termination of this Agreement or the Closing and shall be
subject to all applicable Legal Requirements.

     6.7 Cooperation.

     (a) The Parties shall reasonably cooperate with each other and with their respective
representatives in connection with any steps required to be taken as part of their respective
obligations under this Agreement, and shall (i) furnish upon written request to each other such
further information; (ii) execute and deliver to each other such other documents; (iii) cooperate
and provide reasonable assistance during any payroll transition; and (iv) do such other acts and
things, all as the other Party may reasonably request, for the purpose of carrying out the intent
of this Agreement and the contemplated transaction.

     (b) Buyer, upon reasonable notice from Seller, during normal business hours, will cooperate
with Seller in regard to the preparation, filing, handling and appeals of all cost reports relating
to the Business for relevant periods or required as a result of the transactions described herein,
including, without limitation, those relating to the Medicare and Medicaid programs. Each Party
will, upon reasonable notice to the other, during normal business hours, and subject to applicable
Legal Requirements regarding privilege or confidentiality of patient records, provide reasonable
access to the other Party to all records of the Business and will allow the other Party to copy any
documents reasonably relating to the cost reports and appeals thereof. Each Party agrees to
forward to the other copies of all correspondence relating to the cost reports received from
Medicare, Medicaid, TRICARE, or any other third party payor within five (5) business days of
receipt. Each Party also agrees to inform the other of all audits or other proceedings with
respect to the cost reports within five (5) business days of notification. Additionally, each
Party agrees to use its reasonable best efforts to ensure the other’s right of access for at least
three (3) years from the Closing Date in the event of any subsequent sale of the Business.

     6.8 Costs and Charges.

     (a) Transfer and Other Taxes. Seller shall be responsible for the cost of any and
all state, county, local and municipal transfer and/or excise stamps or Taxes, however denominated,
required as a result of the transfer of the Real Property and other Acquired Assets hereunder to
Buyer. Buyer shall solely bear the cost of placing a mortgage or deed of trust, if any, on the Real
Property, including any and all state, county and municipal mortgage Taxes.

     (b) Title and Recording Charges. Buyer shall be responsible for the cost of: (i)
recording fees for the Deeds; (ii) the cost of any title search and title insurance commitment
fees;

 - 28 - 

 

(iii) the cost of owner’s Title Policy; and (iv) the cost of recording fees for any Buyer
financing documents.

     (c) Professional Fees. Buyer and Seller shall each pay their own professionals’ fees
and expenses, including those of attorneys, investment bankers and accountants.

     6.9 Employees.

     (a) Except as set forth on Schedule 6.9(a), Buyer shall offer employment to all
employees of the Seller who are employed by the Seller and not on leave of any sort as of the
Closing, and shall continue such employment for employees who accept such offer for no less than
ninety (90) days, with a position at the salary or wage no lower than the position and salary or
wage of such Transferred Employee immediately preceding the Effective Time. The only employees of
Seller who are on leave as of the Execution Date are identified on Schedule 6.9(a).
Notwithstanding the foregoing, Buyer shall not be required to hire any former employee of Buyer
whose employment record indicates such person is ineligible for rehire with Buyer (consistent with
Buyer’s standard practices with respect to employment of former employees). For purposes of this
Agreement, employees who accept employment with the Buyer shall be referred to herein as the
"Transferred Employees.”

     (b) From and after the Effective Time, Buyer shall provide (or cause to be provided) all
Transferred Employees with benefits and Employee Benefit Plans and programs substantially
comparable to the benefits and employee benefit plans and programs provided to similarly situated
employees of Buyer or its Affiliates. For purposes of eligibility to participate in and vesting of
benefits under all such Employee Benefit Plans and programs, each Transferred Employee shall be
credited with all of his or her service with Seller and any Seller Affiliate. In addition, Buyer
shall cause each such Buyer employee benefit plan or program that is a health or welfare plan to
(i) waive or cause to be waived any waiting period and any preexisting condition or restriction for
Transferred Employees and their dependents and (ii) credit each Transferred Employee for all
deductibles paid by such Transferred Employee under the corresponding Seller or Seller Affiliate
Employee Benefit Plan for the portion of the plan year preceding the Closing Date, provided Buyer
or the administrator of Buyer’s Employee Benefit Plan provides to Seller the data necessary for
Seller to comply with this clause (ii).

     (c) Seller shall not increase the compensation or benefits of any officers from the Execution
Date through the Effective Time.

     (d) Buyer shall cause a qualified defined contribution plan maintained by Buyer or a Buyer
Affiliate to accept as a rollover contribution each Transferred Employee’s eligible rollover
distribution, both cash and in kind in the form of any outstanding loans, from the Seller’s defined
contribution plan. Notwithstanding the foregoing, if Buyer determines in good faith within thirty
(30) days following the Execution Date that a qualified defined contribution plan maintained by
Buyer or a Buyer Affiliate is unable to accept as a rollover contribution the portion of any such
Transferred Employee’s distribution that represents an outstanding loan established under Seller’s
defined contribution plan, then Buyer shall offer to each of such Transferred Employees an
alternative arrangement that complies with applicable Legal Requirements to hold such Transferred
Employee harmless against the acceleration of the repayment of such loan and the

 - 29 - 

 

adverse tax consequences associated with any such acceleration. Such alternative arrangement
may include, among other options, Buyer’s offering to make a short-term, bridge loan to
each of such Transferred Employees for the outstanding balance of his or her participant loan under
Seller’s defined contribution plan (the proceeds of which shall be used to repay such outstanding
participant loan under Seller’s defined contribution plan) in consideration for the commitment by
each of such Transferred Employees who accept Buyer’s offer to repay such short-term, bridge-loan
as soon as administratively feasible following the completion of the rollover of the distribution
from Seller’s defined contribution plan to Buyer’s defined contribution plan with proceeds of a new
participant loan from Buyer’s defined contribution plan. Buyer further agrees to indemnify and
hold Seller, MedCath, and Investor Members harmless from and against any claim asserted by a
Transferred Employee arising from the acceleration of any repayment of any loan established under
Seller’s defined contribution plan as a result of this transaction and/or the adverse tax
consequences associated with such acceleration.

     (e) Effective as of Closing, Buyer shall (i) credit each Transferred Employee with his or her
Accrued PTO, (ii) make such Accrued PTO available to such Transferred Employee at the same times
and in the same form as such Accrued PTO was available under Seller’s Employee Benefit Plans and
(iii) provide such Accrued PTO in addition to, and not in lieu of, any paid time off accrued for
service from and after the Closing under Buyer’s employee benefit plans.

     (f) Notwithstanding any other provision of this Agreement to the contrary, (i) Seller or a
Seller Affiliate shall retain sponsorship of each Employee Benefit Plan, program, or arrangement
sponsored by Seller or any Seller Affiliate, (ii) Buyer shall not be entitled to any asset of (or
associated with), or assume or be liable for any obligation of, any Employee Benefit Plan (or
associated contract) or other such Employee Benefit Plan, program, or arrangement sponsored by
Seller or any Seller Affiliate, and (iii) no Employee Benefit Plan (or associated contract) or
other such Employee Benefit Plan, program, or arrangement sponsored by Seller or any Seller
Affiliate shall be considered to be a purchased “Asset,” a “Contract,” or an “Assumed Liability”
for purposes of this Agreement.

     (g) Seller or a Seller Affiliate shall provide continuation coverage, to the extent it is
required to do so under COBRA, (i) to all former employees of Seller (and its Affiliates) who incur
COBRA “qualifying events” prior to the Effective Time (and their covered dependents) and (ii) to
all employees who do not become Transferred Employees (and their covered dependents). Buyer shall
be responsible and liable for (and Seller shall not be so responsible or liable for) providing
COBRA continuation coverage to all Transferred Employees and their dependents who experience a
qualifying event after the Effective Time.

     (h) Buyer shall employ and retain for such period of time following the Closing Date such
number of Transferred Employees as shall be necessary to avoid any potential liability by Seller
for a violation of the Workers Adjustment and Retraining Notification Act, 29 U.S. Stat. § 2101 et
seq. (the “WARN Act”), attendant to Seller’s (or Seller Affiliate’s) failure to notify such
Transferred Employees of a “mass layoff” or “plant closing” (as such terms are defined in the WARN
Act). Buyer shall be liable and responsible for any notification required under the WARN Act (or
under any similar state or local Laws) and Buyer shall indemnify and hold Seller and its Affiliates
harmless from and against any liability asserted against Seller or any Seller affiliate under the
WARN Act as a result of Buyer’s failure to comply with the provision of the

 - 30 - 

 

WARN Act as of or after the Closing Date or Buyer’s failure to comply with the provisions of
this Section 6.9(h).

     (i) At the Closing, Seller shall deliver to Buyer copies of all personnel records of the
Transferred Employees. Seller shall coordinate with Buyer promptly after the Execution Date to
provide Buyer reasonable access to employees of Seller and its Affiliates and shall provide to
Buyer employee data and information in each case to complete the documentation necessary to enroll
Transferred Employees in the employee benefit plans to be provided to Transferred Employees by
Buyer and its Affiliates from and after the Effective Time.

     6.10 Medicare and Medicaid Cost Reports. Seller shall timely file all Medicare and
Medicaid cost reports for all cost reporting periods prior to the Effective Time for which the
deadline for filing will arise after the Closing Date in accordance with all applicable Legal
Requirements. Seller shall be liable for any Medicare or Medicaid overpayments or any other
financial obligations arising from any adjustments or reductions in Medicare or Medicaid
reimbursement for the period of time prior to the Effective Time or for any other obligations
imposed by either the Medicare or Medicaid program for the period of time prior to the Effective
Time.

     6.11 Non-Competition and Non-Solicitation.

     (a) Except as provided below in this Section 6.11, each of Seller, MedCath and
Investor Members, in consideration for the payment due to them under Section 1.5(c) hereof,
 covenants and agrees that from and after the Execution Date and until the fifth (5th) anniversary
of the Execution Date (the “Noncompetition Period”), neither he, she, it nor any of his, her or its
Affiliates or Affiliated Persons shall, directly or indirectly, engage anywhere within the
Prohibited Territory in the ownership, management, operation, administration or control of, or
invest in, be employed by or otherwise provide administrative, employment or consulting services to
any Person engaged in or planning to become engaged in the ownership, management, operation,
administration or control of, a hospital that provides acute care cardiac services, cardiac
catheterization laboratory, cardiac diagnostic imaging center, cardiac management services
organization, heart treatment center or program or any other business or business activity which is
substantially similar to the Business.  Notwithstanding the foregoing, Seller, MedCath and Investor
Members each shall be permitted to (i) own not more than three percent (3%) of the outstanding
shares of a publicly-held entity which has shares listed for trading on a securities exchange
registered with the Securities and Exchange Commission or through the automated quotation system of
a registered securities association; (ii), with respect to each Investor Member licensed to
practice medicine in the State of Ohio, serve as a medical director at a hospital or maintain a
private practice for the performance of professional medical services excluding the provision of
any cardiac diagnostic imaging, cardiac catheterization laboratory or cardiac management services;
provided, however, that the restrictions set forth in this Section 6.11
shall not apply to such Investor Member’s performance of cardiac diagnostic imaging services
performed in an office-based setting and billed under such Investor Member’s provider number; and
(iii), with respect to each Investor Member licensed to practice medicine in the State of Ohio,
maintain its ownership interest in effect as of the Execution Date in the facilities  known as “The
Medical Center at Elizabeth Place” or “Dayton Rehabilitation Institute” for so long as such
facilities do not provide acute care cardiac services other than

 - 31 - 

 

those services provided by such facilities as of the Execution Date.  Each Investor Member
that is a professional organization that holds an investment interest in Seller on behalf of one or
more physicians agrees to cause such physicians to comply with the restrictions set forth in this
Section 6.11.

     (b) Except for the services to be performed or provided pursuant to the Transition Services
Agreement, if any, during the Noncompetition Period, each of Seller, MedCath and Investor Members
agrees not to, directly or indirectly, within the Prohibited Territories (i) induce or attempt to
induce any employee of Seller who becomes an employee of Buyer or its Affiliates in connection with
the purchase of the Acquired Assets to leave the employ of Buyer or its Affiliates; (ii) in any way
interfere with the relationship between Buyer or its Affiliates and any such employee; (iii) employ
or otherwise engage as an employee, independent contractor or otherwise any such employee of Buyer
or its Affiliates; or (iv) induce or attempt to induce any customer, supplier, licensee or other
Person to cease doing business with Buyer or its Affiliates or in any way interfere with the
relationship between any such customer, supplier, licensee or other Person and the Buyer or its
Affiliates, provided that general advertising in the media to which an employee responds and which
results in employment by Seller or Parent shall not be a violation of this Agreement.

     (c) If, at the time of enforcement of this Section 6.11, a court holds that the
restrictions stated herein are unreasonable under circumstances then existing, the Parties hereto
agree that the maximum duration, scope or geographical area reasonable under such circumstances
shall be substituted for the stated period, scope or area and that the court shall be allowed to
revise the restrictions contained herein to cover the maximum duration, scope and area permitted by
law. The Parties agree that money damages would be an inadequate remedy for any breach of this
Section 6.11. Therefore, in the event of a breach or threatened breach of this
Section 6.11, the Buyer or its successors or assigns may, in addition to any other rights
or remedies existing in their favor, apply to any court of competent jurisdiction for specific
performance and/or injunctive or other relief in order to enforce, or prevent any violations of,
the provisions of this Section 6.11.

     (d) Notwithstanding anything herein to the contrary:

     (i) Nothing herein shall restrict or prohibit any competition by hospitals and other
healthcare facilities owned or managed by an unrelated third party which after the Closing
Date purchases a majority of the capital stock of MedCath , merges with or into MedCath,
purchases all or substantially all of its assets or enters into other substantially
comparable transaction (a “MedCath Change of Control”) but only to the extent such
competing hospitals or facilities are owned or managed by such third party as of the date of
the closing of such MedCath Change of Control, and

     (ii) If after the Closing Date, MedCath purchases (whether by purchase of stock, assets
or merger) a third party that owns multiple hospitals or other healthcare facilities, one of
which is in the Prohibited Territory and competes in the Business, there shall be no
violation of this Section 6.11 as long as MedCath causes such competing hospital or
facility to be sold to an unrelated third party within eighteen (18) months.

 - 32 - 

 

     6.12 Change of Name. On or before the Closing Date, Seller shall (a) amend its
charter and take all other actions necessary to change its name to one sufficiently dissimilar to
Seller’s present name, in Buyer’s judgment, to avoid confusion, and (b) take all actions requested
by Buyer to enable Buyer to use any names acquired by Buyer at the Closing. From and after the
Closing Date, Seller shall make no further use of (i) the name “Dayton Heart Hospital LLC” or any
derivative thereof, or (ii) any other name that, in Buyer’s reasonable judgment, is sufficiently
similar to “Dayton Heart Hospital, LLC” so as to potentially cause confusion.

     6.13 Contact with Employees and Vendors. Prior to the Closing, neither the Buyer nor
any of the Buyer’s representatives shall contact or otherwise communicate with any employees,
vendors or suppliers of the Seller in connection with or regarding the transactions contemplated
hereby, except to the extent approved in writing by Edwin French or his designee.

     6.14 Conduct of the Company. During the period from the date of this Agreement and
continuing until the Closing, the Seller agrees that, except as expressly contemplated or permitted
by this Agreement or the Schedules; as required by any Legal Requirement; or to the extent that the
Buyer shall otherwise consent in writing, which consent shall not be unreasonably withheld,
conditioned or delayed:

     (a) the Seller shall use reasonable efforts to carry on its business in the usual, regular and
ordinary course in all material respects, in substantially the same manner as heretofore conducted;
provided, however, that no action by the Seller with respect to matters
specifically addressed by any other provision of this Section 6.14 shall be deemed a breach
of this Section 6.14, unless such action would constitute a breach of one or more of such
other provisions;

     (b) other than as may be required by or in conformance with Legal Requirements in order to
permit or facilitate the consummation of the transactions contemplated hereby or the transactions
disclosed in the Schedules, the Seller shall not sell, encumber or otherwise dispose of, or agree
to sell, encumber or otherwise dispose of, any of its material assets other than in the ordinary
course of business consistent with past practice;

     (c) other than as required by an existing contract or agreement as in effect on the date
hereof and other than in the ordinary course of business consistent with past practice, the Company
shall not (i) increase the amount of cash compensation or severance pay of any officer, (ii) make
any material increase in, or commitment to increase materially, any employee benefits or
(iii) adopt or make any commitment to adopt any material new Employee Benefit Plan or make any
material contribution, other than regularly scheduled contributions, to any Employee Benefit Plan.

     6.15 Billing for Transition Patients.

     (a) To assist in determining the payments to Buyer and Seller from payors for services
provided to patients admitted to the Hospital prior to the Effective Time and discharged after the
Effective Time (“Transition Patients”), the parties shall take the following actions: If
the Hospital is reimbursed on an interim basis under the Medicare program on a periodic interim
payment (“PIP”) basis and if Buyer receives any PIP payments from the Medicare program or

 - 33 - 

 

other payor associated with the operations of the Hospital relating solely to periods prior to
the Effective Time, Buyer shall promptly forward such payment to Seller. If Buyer or Seller
receives any PIP payments from the Medicare program or other payor associated with the operations
of the Hospital relating to periods prior to the Effective Time, or where cut-off billings cannot
be done as of the Effective Time, the Parties agree to value such amounts applicable to the period
prior to the Effective Time on the one hand, and value such amounts applicable to the period after
the Effective Time on the other hand, based on the actual date services, procedures, supplies and
devices were rendered to the Transition Patient as determined by a review of patient records. The
amount of PIP payments valued and owed to Buyer as described in the prior sentence shall promptly
be paid to Buyer by Seller if Seller receives the PIP payment from the payor, and the amount valued
and owed to Seller as described in the prior sentence shall promptly be paid to Seller by Buyer if
Buyer receives the PIP payment.

     (b) With respect to Medicare, Medicaid, TRICARE and other patients admitted to the Hospital
prior to the Effective Time and discharged after the Effective Time who are enrolled in health
insurance programs that reimburse for services and items on a cost- or case-based methodology
(“Straddle Patients”), Seller shall prepare cut-off claims through the Effective Time for
all Straddle Patients in, or receiving services from, the Hospital. If Buyer receives any payments
for Straddle Patients associated with the operations of the Hospital relating solely to periods
prior to the Effective Time, Buyer shall promptly forward such payment to Seller.

ARTICLE 7

TERMINATION

     7.1 Termination. This Agreement may be terminated at any time prior to the Closing:

     (a) by the mutual written consent of the Buyer and the Seller;

     (b) by the Seller, if there has been a material breach by the Buyer of any covenant,
representation or other agreement or term contained herein which has prevented the satisfaction of
any condition to the obligations of the Seller at the Closing and such breach has not been waived
by the Seller or cured by the Buyer within ten business days after the Buyer’s receipt of written
notice thereof from the Seller;

     (c) by the Buyer, if there has been a material breach by the Seller of any covenant,
representation or other agreement or term contained herein which has prevented the satisfaction of
any condition to the obligations of the Buyer at the Closing and such breach has not been waived by
the Buyer or cured by the Seller within ten business days after the receipt of written notice
thereof from the Buyer;

     (d) by the Seller, if the transactions contemplated hereby have not been consummated on or
before May 16, 2008; provided that the Seller shall not be entitled to terminate this
Agreement pursuant to this Section 7.1(d) if the Seller’s willful breach of this Agreement
has prevented the consummation of the transactions contemplated hereby;

 - 34 - 

 

     (e) by the Buyer, if the transactions contemplated hereby have not been consummated on or
before May 16, 2008; provided that the Buyer shall not be entitled to terminate this
Agreement pursuant to this Section 7.1(e) if the Buyer’s willful breach of this Agreement
has prevented the consummation of the transactions contemplated hereby; or

     (f) by the Buyer upon (i) the failure of the representations and warranties of Seller
described in Sections 2.1(b), 2.3 or 2.10 to be true and correct in all
material respects as of the Closing Date, (ii) if a Material Environmental Problem or Material
Structural Problem exists (as such terms are defined by the Escrow Agreement) or (iii) a
Governmental Authority orders in writing that the transactions contemplated by this Agreement not
be completed or notifies Buyer or Seller in writing that it is investigating such transaction for
compliance with Legal Requirements.

     The party desiring to terminate this Agreement pursuant to clauses (b), (c), (d), (e) or (f)
of this Section 7.1 shall give written notice of such termination to the other party
hereto.

     7.2 Effect of Termination. Subject in all events to the terms of Section 7.2,
in the event this Agreement is terminated by either the Buyer or the Seller as provided in
Section 7.1, the provisions of this Agreement shall immediately become void and of no
further force and effect (other than Section 6.5 (Confidentiality), this ARTICLE 7 and
ARTICLE 8, each of which shall survive the termination of this Agreement), and there shall be no
liability on the part of the Buyer or the Seller to any other party hereto except that the Escrow
Funds shall be paid by the Escrow Agent in accordance with Section 7.3 and any party whose
breach or violation of the terms of this Agreement resulted in the termination of this Agreement
shall be liable for damages incurred by the other party hereto.

     7.3 Disposition of Deposit Upon Termination. If Buyer terminates this Agreement as a
result of Seller’s material breach as described in Section 7.1(b) or as described in
Section 7.1(f), the Buyer’s Deposit shall be paid and delivered by the Escrow Agent to
Buyer. If this Agreement terminates for any other reason or cause, then Buyer’s Deposit shall be
paid and delivered by the Escrow Agent to Seller.

ARTICLE 8

INDEMNIFICATION

     8.1 Survival. Subject to Section 8.5 hereof, all parties agree that their
respective representations, warranties, covenants and agreements contained in this Agreement shall
survive the Closing.

     8.2 Indemnification — General.

     (a) Subject to the other provisions of this ARTICLE 8, the Seller shall defend, indemnify and
hold harmless, the Buyer and its respective directors, officers, employees, managers, members and
Affiliates (the “Buyer Indemnified Parties”) from and against any and all Losses suffered or
incurred by them after the date hereof as a result of or arising out of:

 - 35 - 

 

     (i) the falsity or incorrectness of or breach of any representation or warranty of
Seller in this Agreement;

     (ii) the failure by Seller to perform any covenant or agreement applicable to it in the
Transactions ;

     (iii) any obligation, liability or claim relating to the (x) Excluded Liabilities or
(y) the ownership or operation of the Business or the Acquired Assets prior to the Effective
Time, except to the extent specifically constituting Assumed Liabilities; and

     (iv) a violation by MedCath (or any Affiliate or Affiliated Persons thereof) or by any
of Investor Members of the restrictions imposed by Section 6.11 or
Section 9.17, provided that only the person or party that violated
Section 6.11 or Section 9.17 shall be severally obligated to indemnify the
Buyer Indemnified Parties for Losses arising from such violation.

     (b) Subject to the other provisions of this ARTICLE 8, the Buyer shall defend, indemnify and
hold harmless, the Seller and its directors, officers, employees, managers, members and Affiliates
(the “Seller Indemnified Parties”) from and against any and all Losses suffered or incurred by them
after the date hereof as a result of or arising out of:

     (i) the falsity or incorrectness of or breach of any representation or warranty of
Buyer in this Agreement;

     (ii) the failure by Buyer to perform any covenant or agreement applicable to it in the
Transactions; and

     (iii) any obligation, liability or claim relating to (x) the Assumed Liabilities or (y)
the ownership or operation of the Business or the Acquired Assets from and after the
Effective Time.

     8.3 Method of Asserting Claims. All claims for indemnification by any Indemnified
Party under this ARTICLE 8 shall be asserted and resolved as follows:

     (a) Claims Other Than Third Party Claims. In the event any Indemnified Party should have a
claim under this ARTICLE 8 against an Indemnifying Party that does not involve a Third Party Claim
(as described in Section 8.3(b)), the Indemnified Party shall promptly give written notice
and the details thereof, including copies of all relevant information and documents (collectively,
an “Indemnity Notice”), to the Indemnifying Party within a period of thirty (30) days following the
discovery of the claim by the Indemnified Party (the “Claim Notice Period”). The failure by the
Indemnified Party to give the Indemnity Notice within the Claim Notice Period shall not impair the
Indemnified Party’s rights hereunder except to the extent (and only to the extent) that the
Indemnifying Party demonstrates that it has been materially prejudiced thereby.

     (b) Third Party Claims. If any claim or demand in respect of which an Indemnified Party might
seek indemnity under this ARTICLE 8 is asserted against such Indemnified Party by a Person other
than a Seller Indemnified Party or a Buyer Indemnified Party (as applicable) (a

 - 36 - 

 

“Third Party Claim”), the Indemnified Party shall give written notice and the details thereof
including copies of all relevant pleadings, documents and information (collectively a “Third Party
Claim Notice”) to the Indemnifying Party within a period of twenty (20) days following the
assertion of the Third Party Claim against the Indemnified Party (the “Third Party Claim Notice
Period”). If the Indemnified Party fails to provide the Third Party Claim Notice within the Third
Party Claim Notice Period, the Indemnifying Party will not be obligated to indemnify the
Indemnified Party with respect to such Third Party Claim to the extent (and only to the extent)
that the Indemnifying Party’s ability to defend has been materially prejudiced by such failure of
the Indemnified Party. The Indemnifying Party will notify the Indemnified Party within a period of
ten (10) days after the receipt of the Third Party Claim Notice by the Indemnifying Party (the
"Third Party Claim Response Period”) whether or not the Indemnifying Party desires, at its sole
cost and expense, to defend the Indemnified Party against such Third Party Claim.

     If the Indemnifying Party notifies the Indemnified Party within the Third Party Claim Response
Period that the Indemnifying Party desires to defend the Indemnified Party against the Third Party
Claim, then the Indemnifying Party at its sole cost and expense shall defend, with counsel
reasonably satisfactory to the Indemnified Party, such Third Party Claim by all appropriate
proceedings, which proceedings will be diligently prosecuted to a final conclusion or will be
settled at the discretion of the Indemnifying Party (with the consent of the Indemnified Party,
which shall not be unreasonably withheld and which shall be deemed to be provided if such
settlement provides a release to the Indemnified Party without the payment of any amount by the
Indemnified Party). The Indemnified Party will cooperate in such defense at the sole cost and
expense of the Indemnifying Party. The Indemnified Party may, at its sole cost and expense, at any
time prior to the Indemnifying Party’s delivery of the notice referred to in the last sentence of
the preceding paragraph, file any pleadings or take any other action that the Indemnified Party
reasonably believes to be necessary or appropriate to protect its interests. The Indemnified
Party, at its expense, may participate in, but not control, any defense or settlement of any Third
Party Claim conducted by the Indemnifying Party pursuant to this Section 8.3(b).
Notwithstanding the foregoing, if the named parties to any proceeding include both the Indemnified
Party and the Indemnifying Party and, in the reasonable opinion of counsel to the Indemnified
Party, representation of both parties by the same counsel would be in conflict or otherwise
inappropriate due to actual or potential differing interests between them, then the Indemnified
Party shall be entitled to retain separate counsel for the Indemnified Party, at the expense of the
Indemnifying Party (provided that the costs and expenses of such separate counsel are reasonable).

     If the Indemnifying Party fails to notify the Indemnified Party within the Third Party Claim
Response Period that the Indemnifying Party desires to defend the Third Party Claim or if the
Indemnifying Party gives such notice but fails to prosecute diligently or settle the Third Party
Claim, then the Indemnified Party shall defend, at the sole cost and expense of the Indemnifying
Party, the Third Party Claim by all appropriate proceedings, which proceedings will be prosecuted
by the Indemnified Party in a reasonable manner and in good faith or will be settled at the
discretion of the Indemnified Party (with the consent of the Indemnifying Party, which shall not be
unreasonably withheld). The Indemnifying Party may, at its sole cost and expense, cooperate in
such defense.

 - 37 - 

 

     8.4 Continued Liability for Indemnity Claims. The liability of any Indemnifying Party
hereunder with respect to claims hereunder shall continue except to the extent limited by
Section 8.5 hereof and, with respect to any such indemnification claims duly and timely
made, thereafter until the Indemnifying Party’s liability therefor is finally determined and
satisfied.

     8.5 Limitations on and Expiration of Indemnification. Notwithstanding anything to the
contrary contained in this Agreement, the Indemnified Party’s rights to indemnification against the
Indemnified Party shall be limited as follows:

     (a) The representations, warranties, covenants and agreements described in this Agreement, and
any other agreements, certificates or documents delivered at the Closing in connection with the
transactions contemplated by, and expressly described in, this Agreement shall survive the Closing
Date; provided, however, that the representations and warranties of each Party set forth in this
Agreement shall expire and be of no further force or effect on the date that is eighteen (18)
months after the Closing Date; except that the following representations and warranties shall have
no expiration date: Section 2.1, Section 2.3(a) and Section 2.5 of this
Agreement; and further the representations and warranties contained in each of Section 2.8,
Section 2.10 and Section 2.15 of this Agreement shall survive and continue in full
force and effect until ninety (90) days after expiration of the applicable statue of limitations
(collectively the “Survival Period”). Notwithstanding anything to the contrary contained in this
Agreement, no claim for indemnification may be made, directly or indirectly, after the expiration
of the Survival Period. Provided, however, with respect to any matter as to which
a reasonable and good faith claim for indemnification has been duly noticed hereunder and is
pending or unresolved at the end of the Survival Period, such claim shall continue to be covered by
the indemnification provisions hereof, and the Indemnifying Party shall remain potentially liable
therefor, until resolved.

     (b) No Indemnified Party shall be entitled to indemnification for any Loss incurred or
suffered by such Indemnified Party arising under Section 8.2(a)(i) or 8.2(b)(i)
hereof unless such Loss is greater than Fifteen Thousand Dollars ($15,000) (the “De Minimis
Amount”) and unless such Loss, together with all other Losses that are greater than the De Minimis
Amount, exceeds Two Hundred and Fifty Thousand Dollars ($250,000.00) (the “Basket”). When and if
the Basket is exceeded, the Indemnifying Party shall indemnify the Indemnified Party for Losses
only to the extent the amount thereof exceeds the amount of the Basket. The limitation set forth
in this Section 8.5(b) shall not apply to any Loss incurred or suffered by any Buyer
Indemnified Party arising under Section 8.2(a)(i) as a result of Seller’s breach of the
representations and warranties described in Sections 2.1, 2.3(a), 2.5, 2.8,
2.15, or 2.16.

     (c) Except as otherwise provided in this Section 8.5(c), aggregate indemnification
obligations arising under Section 8.2(a)(i) or Section 8.2(b)(i) hereof shall be
limited to Ten Million Dollars ($10,000,000.00) (the “Indemnification Cap”); provided, however,
that (i) the aggregate indemnification obligations of the Seller with respect to Losses incurred or
sustained by the Buyer Indemnified Parties as a result of a breach of Sections 2.1, 2.3(a),
2.5, 2.8, 2.15, or 2.16 of this Agreement, together with all other
Losses for which indemnification is sought under Section 8.2(a)(i) shall not exceed the
Purchase Price and (ii) the aggregate indemnification obligations of the Seller with respect to
Losses incurred or sustained arising under Sections 8.2(a)(ii), 8.2(a)(iii) or
8.2(a)(iv) shall not be limited, and (iii) the aggregate

 - 38 - 

 

indemnification obligations of the Buyer with respect to Losses incurred or sustained arising
under Section 8.2(b)(ii) or 8.2(b)(iii) shall not be limited.

     (d) Neither Party shall be entitled to recover any Losses to the extent it actually recovers,
if at all, any insurance proceeds from any policies which cover such Losses, but net of the
reasonable and actual costs and expenses in making such recovery.

     (e) In no event shall an Indemnifying Party be liable to an Indemnified Party for any
consequential, special, or punitive damages, except to the extent that such consequential, special,
or punitive damages are payable by such Indemnified Party to a third party pursuant to a Third
Party Claim against such Indemnified Party for which such Indemnified Party is otherwise entitled
to indemnity under this ARTICLE 8.

     (f) The Parties covenant to use commercially reasonable efforts to mitigate any Losses to the
same extent as would a reasonable and prudent Person to whom no indemnity were available.

     (g) AFTER THE CLOSING DATE, THE REMEDIES CONTAINED IN THIS ARTICLE 8 SHALL CONSTITUTE THE SOLE
AND EXCLUSIVE REMEDIES OF THE SELLER INDEMNIFIED PARTIES AND THE BUYER INDEMNIFIED PARTIES, WHETHER
IN CONTRACT, TORT OR OTHER APPLICABLE LAW, FOR RECOVERIES AGAINST THE OTHER WITH RESPECT TO CLAIMS
FOR BREACH OF ANY COVENANT, AGREEMENT, REPRESENTATION OR WARRANTY CONTAINED IN THE THIS AGREEMENT
OR IN THE EXHIBITS OR SCHEDULES ATTACHED THERETO OR IN THE RELATED AGREEMENTS OR TRANSACTIONS, OR
ANY OTHER CLAIM ARISING IN CONNECTION WITH THE TRANSACTIONS, EXCEPT THAT NOTHING SHALL LIMIT THE
RIGHT OF THE BUYER INDEMNIFIED PARTIES OR SELLER INDEMNIFIED PARTIES TO BRING AN ACTION TO RECOVER
DAMAGES FOR FRAUD OR A KNOWING OR WILLFUL MISREPRESENTATION OR TO BRING AN ACTION FOR INJUNCTIVE
RELIEF.

     (h) Retention of Funds by Seller. Seller hereby agrees that it will not distribute
(i) $1,000,000.00 of the Purchase Price , and (ii) the first $2,000,000.00 of proceeds of Seller’s
Accounts Receivable collected during the twelve (12) month period after the Closing Date (the
“Retention”) to its members for at least twelve (12) months after the Closing Date, and, to the
extent there are unresolved indemnification claims made in good faith pending as of the end of such
twelve (12) month period, Seller shall continue to refrain from distributing such portion of the
Retention which is reasonably necessary to pay such pending claims until such indemnification
claims are finally resolved.

     Seller shall not be dissolved prior to the end of the eighteen (18) month following the
Closing Date.

 - 39 - 

 

ARTICLE 9

MISCELLANEOUS

     9.1 No Shop. Except for the sale of inventory and other assets in the ordinary
course, Seller agrees that, from the date hereof through the date of consummation or earlier
termination of this Agreement, it shall not, and shall not permit any of its Affiliates or
employees or any investment banker, attorney, adviser or other representative of Seller to,
directly or indirectly, (i) offer for sale or solicit offers to buy the Hospital, any part of the
Acquired Assets or any interest in Seller, (ii) hold discussions or negotiate with, or provide
information to, any Person (other than Buyer) with a view towards such an offer or solicitation or
with a view towards a sale of any equity interest in or a merger or consolidation of any entity
owning the Acquired Assets, or (iii) enter into any Contract with any such Person relating to the
sale or other disposition of any of the Hospital or any part of the Acquired Assets.

     9.2 Amendments. This Agreement may not be amended, modified or supplemented, and no
provision hereof shall be waived, without the signed written consent of all the Parties hereto and
clearly expressing such intent.

     9.3 Waiver. Failure to insist upon strict compliance with any of the terms,
covenants, or conditions of this Agreement at any one time shall not be deemed a waiver of such
term, covenant, or condition at any other time, nor shall any waiver or relinquishment of any right
or power herein at any time be deemed a waiver or relinquishment of the same or any other right or
power at any other time.

     9.4 Notices. All notices, payments, or other communications required or permitted
hereunder shall be in writing and shall be deemed to have been duly given only if sent by hand
delivery or by recognized overnight courier, all charges prepaid, addressed as follows (or to such
other addresses as subsequently designated by a Party from time to time pursuant to this
Section 9.4):

If to Seller to:

MedCath Incorporated

10720 Sikes Place, Suite 300

Charlotte, NC 28277

Attn: Chief Executive Officer

Tel. No.: (704) 708-6600

Fax No.: (704) 708-5035

 - 40 - 

 

with a copy to:

MedCath Incorporated

10720 Sikes Place, Suite 300

Charlotte, NC 28277

Attn: General Counsel

Tel. No.: (704) 708-6600

Fax No.: (704) 708-5035

with a copy to:

Moore & Van Allen PLLC

100 N. Tryon Street, Suite 4700

Charlotte, NC 28202-4003

Attn: Hal A. Levinson

Tel. No.: (704) 331-1050

Fax No.: (704) 378-2050

     which copy shall not constitute notice for the purposes of this Agreement.

If to Buyer, to:

Good Samaritan Hospital

Attention: President & Chief Executive Officer

2222 Philadelphia Drive

Dayton, Ohio 45406

Copy to:

Premier Health Partners

Attention: Vice President & Chief Legal Officer

40 West 4th Street, Suite 1800

Dayton, Ohio 45402

     9.5 Counterparts. This Agreement may be executed in any number of counterparts
(including by means of telecopied signature pages or signature pages sent electronically in a .pdf
format), each of which shall be deemed an original, but all of which together shall constitute but
one and the same instrument.

     9.6 Enforceability and Severability. In the event any provision of this Agreement or
portion thereof is found to be wholly or partially invalid, illegal, or unenforceable in any
Proceeding, such provision shall be deemed to be modified or restricted to the extent and in the
manner necessary to render the same valid and enforceable, or shall be deemed severed from this
Agreement, as the case may require, and the balance of this Agreement shall be construed and
enforced to the maximum extent permitted by law, as if such provision had been originally
incorporated herein as so modified or restricted or as if such provision had not been originally
contained herein, as the case may be.

 - 41 - 

 

     9.7 Governing Law. This Agreement shall be construed in accordance with the laws of
the State of Ohio, without regard to conflicts of laws principles.

     9.8 Assignment. This Agreement shall not be assigned or delegated by any Party
without the signed prior written consent of the other Party; provided, however, that Buyer may,
without the written consent of the others (a) assign any or all of its rights and interests
hereunder to one or more of its Affiliates and (b) designate one or more of its Affiliates to
perform its obligations hereunder, provided that such assignment shall not relieve Buyer of any of
its obligations or liabilities hereunder. Absent an express written agreement among the Parties
to the contrary, any assignment, delegation, or designation shall not release a Party from any
obligations under this Agreement, and the delegating or designating Party shall remain liable,
jointly and severally, with any delegate or designee with respect to all obligations of the
delegating or designating Party under this Agreement. Any purported assignment, delegation, or
designation in violation of this Section 9.8 is void.

     9.9 Expenses. Subject to the provisions of Section 9.18(b) below, each Party
will pay its own expenses in connection with the transactions contemplated hereby, whether or not
such transactions shall be consummated.

     9.10 Parties in Interest. All representations, covenants, and agreements contained in
this Agreement by or on behalf of any of the Parties hereto shall bind and inure to the benefit of
the respective successors and permitted assigns (if any) of the Parties hereto.

     9.11 Consents. No consent or approval contemplated hereunder shall be unreasonably
withheld, conditioned, delayed or denied.

     9.12 Third Parties. Except as specifically contained herein, this Agreement does not
and is not intended to create any rights in any Person which is not a Party to this Agreement.

     9.13 Entire Agreement. This Agreement, including the Schedules and Exhibits hereto
and agreements referenced herein, constitutes the sole and entire agreement and understandings of
the Parties with respect to the subject matter hereof, and supersedes and terminates any and all
prior agreements, discussions, negotiations or communications. All Schedules and Exhibits hereto
are incorporated herein by reference.

     9.14 Specific Performance; Injunctive Relief. Each Party shall have the right, in
addition to any other rights and remedies existing in its favor, to enforce its rights and the
obligations of the other Party hereunder not only by an action(s) for damages but also by an
action(s) for specific performance, injunctive and/or other equitable relief, without posting any
bond or other undertaking. The Parties acknowledge and agree that any breach or threatened breach
of any post-Closing covenant by any Party will likely result in some irreparable injury.

     9.15 Headings; Construction. The headings of Articles and Sections in this Agreement
are provided for convenience only and will not affect its construction or interpretation. All
words used in this Agreement will be construed to be of such gender or number as the context
requires. All references to documents, instruments or agreements will be deemed to refer as well to
all addenda, exhibits, schedules or amendments thereto, but only to the extent existing as of the
date hereof.

 - 42 - 

 

     9.16 Applicable Date. Any reference to any Legal Requirements or to any Contract
means same as exists as of the Execution Date and again as of the Closing Date.

     9.17 No Payments for Referrals. Seller, Investor Members, MedCath and Buyer
acknowledge and agree that the Purchase Price has been determined to be consistent with the fair
market value of the Acquired Assets and that no portion of the Purchase Price or any other benefit
granted to any Party under this Agreement is conditioned on any requirement that Seller or Investor
Members make referrals to, be in a position to make or influence referrals to, or otherwise
generate business for, Buyer.

     9.18 Dispute Resolution.

     (a) In the event of any dispute or disagreement between the Parties following the Closing as
to the interpretation of any provision of this Agreement or the performance of any obligations
hereunder the matter, upon the written request of any Party, shall be referred to representatives
designated by each respective Party for resolution binding on the Parties. Such representatives
shall promptly meet in a good faith effort to resolve the dispute. If the representatives do not
agree upon a resolution within thirty (30) calendar days after reference of the matter to them,
each Party shall be free to exercise the remedies available to it under Section 9.18(b).

     (b) If any controversy, dispute or claim arising out or relating in any way to this Agreement
or the transactions contemplated hereunder is not resolved by negotiation pursuant to
Section 9.18(a), then either Party involved in such controversy, dispute or claim may
demand that the controversy, dispute or claim be resolved by binding arbitration in accordance with
the Commercial Arbitration Rules of the American Arbitration Association then in effect by three
arbitrators selected in accordance with such rules unless the parties shall agree on a single
arbitrator. Such arbitrator(s) shall have at least ten (10) years of experience in the healthcare
field. The arbitrators shall not reside or practice primarily in the State of Ohio. The
arbitration proceedings shall be held in Columbus, Ohio or another mutually acceptable neutral
venue. Each Party shall bear all of its own expenses and the arbitrators’ fees and expense shall
be shared equally by the parties to the arbitration; provided, however, that at the conclusion of
the arbitration, the arbitrator shall award costs and expenses (including the costs of the
arbitration previously advanced and the fees and expenses of attorneys, accountants and other
experts) to the prevailing Party or Parties. The decision of the arbitrators shall (i) be rendered
in writing, and concurred in by a majority of the arbitrators, if more than one, and (ii) be final,
binding and conclusive and entitled to be enforced to the fullest extent permitted by law and
entered in any court of competent jurisdiction. To the extent practical, the decision of the
arbitrators shall be rendered no more than thirty (30) days following commencement of proceedings
with respect thereto. The arbitrators shall have the power to grant equitable relief. The
arbitrators shall cause their written decision to be delivered to the Parties. The Parties consent
to the jurisdiction of the foregoing arbitrator or arbitrators and further consent to the
jurisdiction of any state or federal court located in the State of Ohio for the purpose of
enforcing the decision or award of the arbitrators. The Parties agree that service of process may
be made on any such Party by personal delivery or by registered or certified mail addressed to the
appropriate Party at the address for such Party specified in Section 9.4. The submission
to the jurisdiction of the courts referred to above for the purpose of enforcing the decision or
award of the arbitrators shall not (and shall not

 - 43 - 

 

be construed so as to) limit the right of any Party to file or commence a proceeding against
the other in any other court of competent jurisdiction for the purpose of enforcing the decision or
award of the arbitrators if and to the extent permitted by applicable law. In the event any suit
or other legal proceeding is brought for the enforcement of any decision or award of the
arbitrators, the Parties agree that the prevailing Party or Parties shall be entitled to recover
from the other Party or Parties upon final judgment on the merits reasonable attorneys’ fees,
including attorneys’ fees for any appeal and costs incurred in bringing such suit or proceeding.
Notwithstanding anything to the contrary provided in this Section 9.18(b), and without
prejudice to the above procedures, any Party may apply to any court of competent jurisdiction for
temporary injunctive or other provisional judicial relief if such action is necessary to avoid
irreparable damage or to preserve the status quo until such time as the arbitrator is selected and
available to hear such Party’s request for temporary relief.

     9.19 Specific Controls Over the General. The Parties acknowledge the general rule of
contract law that a limited or specific provision will prevail over one that is more broadly
inclusive, and that such rule shall apply to the provisions of this Agreement, with the result that
a recovery prohibited by or unavailable under the language of any one representation, warranty,
covenant or section will not be allowed under an alternative representation, warranty, covenant or
section.

     9.20 Construction. The Parties have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or question of intent or interpretation
arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption
or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any
of the provisions of this Agreement. Any reference to any federal, state, local, or foreign statute
or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless
the context requires otherwise. The word “including” shall mean including without limitation.

     9.21 Incorporation of Exhibits and Schedules. Notwithstanding any provision of this
Agreement to the contrary, Buyer and Seller acknowledge and agree that, with respect to any exhibit
and/or schedule referenced in this Agreement but not completed and attached hereto as of the
Execution Date, Buyer and Seller shall, subject to the terms of Section 6.2 hereof, in
good faith negotiate the contents of such exhibit and/or schedule prior to the Closing Date.
 Subject to the foregoing, the exhibits, schedules and disclosure schedules identified in this
Agreement are incorporated herein by reference and made a part hereof. Any matter contained in any
one section or schedule shall be deemed to be included in any other section or schedule to the
extent it is reasonably apparent on its face that such information is relevant to another section
or schedule.

     9.22 Execution by Investor Members. Notwithstanding anything herein to the contrary,
as of the Execution Date all of the Investor Members of Seller have not executed this Agreement,
however, this Agreement shall nonetheless be a binding agreement upon the Buyer, Seller and the
Investor Members who have executed this Agreement as of the Executtion Date. Seller shall seek to
have all of its Investor Members execute this Agreement prior to the Closing Date, provided that
their execution hereof shall not be a condition to the Closing of the transactions contemplated by
this Agreement. 

 - 44 - 

 

[Signature pages to follow]

 - 45 - 

 

     IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement effective as of the
21st day of March, 2008.

	 	 	 
	     SELLER

	 	HEART HOSPITAL OF DTO, LLC
	 

	 	By: DTO Management, Inc., its manager
	 
	 	 
	 

	 	By: /s/ O. Edwin French
	 

	 	Name: O. Edwin French
	 

	 	Title: President
	 
	 	 
	     BUYER

	 	GOOD SAMARITAN HOSPITAL
	 
	 	 
	 

	 	By: /s/ James Pancoast
	 

	 	Name: James Pancoast
	 

	 	Title: President and CEO
	 
	 	 
	     Solely for the
purposes of the agreements
set forth in Sections 6.
11 and 9.17 of the Agreement:

	 	MEDCATH INCORPORATED
	 

	 	By: /s/ O. Edwin French
	 

	 	Name: O. Edwin French
	 

	 	Title: President
	 
	 	 
	     Solely for the purposes of the agreements set forth
in Sections 6. 11
and 9.17 of the Agreement:

	 	INDIVIDUAL INVESTOR MEMBER:
	
	 	 

	 	 	 
	 

	 	 
	 

	 	     Signature :
	 
	 	 
	 

	 	 
	 

	 	     Print Name :
	 
	 	 
	 

	 	 
	 

	 	     Date

 - 46 - 

 

Exhibit A

Defined Terms

     Index of Terms Defined Elsewhere in this Agreement (and not defined below)

	 	 	 
	Term	 	Section
	Accounts Receivable
	 	1.1(k)
	Accrued PTO
	 	1.3(d)
	Acquired Assets
	 	1.1
	Agreement
	 	Preamble
	Assignment and Assumption Agreement
	 	4.4(b)
	Assumed Contracts
	 	1.1(d)
	Assumed Liabilities
	 	1.3
	Buyer
	 	Preamble
	Buyer’s Closing Documents
	 	5.4
	Closing
	 	1.6(a)
	Closing Date
	 	1.6(a)
	Confidential Information
	 	6.6
	Deed
	 	4.4(c)
	Effective Time
	 	1.6(b)
	Excluded Assets
	 	1.2
	Excluded Contracts
	 	1.2(a)
	Excluded Liabilities
	 	1.4
	Excluded Records
	 	1.2(b)
	License
	 	1.1(f)
	Licenses
	 	1.1(f)
	Permitted Real Property Encumbrances
	 	1.8
	Personal Property
	 	1.1(a)
	Prepaid Expenses
	 	1.1(i)
	Purchase Price
	 	1.5(a)
	Purchased Inventory
	 	1.1(h)
	Real Property Leases
	 	1.1(e)
	Seller
	 	Preamble
	Seller’s Closing Documents
	 	4.4
	Transferred Employees
	 	6.9(a)
	Transferred Records
	 	1.1(j)
	WARN Act
	 	6.9(h)

 

 

     For purposes of this Agreement, the following terms and variations thereof have the meanings
specified or referred to in this Exhibit A:

     “Agreement” has the meaning contained in the first paragraph of this Agreement.

     “Affiliate” or “Affiliated Persons” means, with respect to any Person, any Person directly or
indirectly Controlling, Controlled by or under common Control with such Person.

     “Applicable Law” means any law, statute, ordinance, regulation, rule, interpretation, or order
of any Governmental Authority of any foreign country, the United States or Ohio, as of the date
hereof.

     “Business” means the full range of healthcare services of the Hospital as an acute care
hospital, including its: inpatient and outpatient services, emergency care services, heart and
vascular center and cardiac rehabilitation services, surgical clinic services, cardiac
catheterization laboratory, diagnostic imaging services, ambulatory care services and ambulatory
diagnostic center services.

     “COBRA” means Section 4980B of the Code and Sections 601 through 608, inclusive, of ERISA.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Contract” means any contract or agreement (whether written or oral) (a) under which Seller
has or may acquire any rights or benefits used primarily in the Business, (b) under which Seller
has or may become subject to any obligation or liability in the Business, or (c) by which Seller or
any of the assets owned or used by Seller is or may become bound (including the Real Property
Leases) in the Business.

     “Control” (and variations thereon) means the possession, directly or indirectly, of the power
to direct the management and policies of a Person whether through the ownership of voting
securities, by contract, or otherwise; and control shall be presumed if a Person owns more than
fifty percent (50%) of the voting equity in any other Person.

     “EEOC” means Equal Employment Opportunity Commission.

     “Employee Benefit Plan” means any employee benefit plan, program, arrangement, fund, policy,
practice, or Contract with respect to which, through which, or under which the Seller or any Seller
ERISA Affiliate (as hereinafter defined) has any liability to provide benefits or compensation to
or on behalf of employees, former employees, or independent contractors of the Seller with respect
to the Business, whether formal or informal, written or not written, including (a) any bonus,
incentive compensation, profit sharing, stock option, deferred compensation, commission, severance
pay, golden parachute, or other compensation plan or rabbi trust; (b) any “employee benefit plan”
(as defined in Section 3(3) of ERISA); and (c) any stock purchase, vacation, scholarship, day care,
prepaid legal services, dependent care, or other fringe benefit plans, programs, arrangements,
Contracts, or practices.

 - 2 - 

 

     “Encumbrance” means any charge, claim, equitable interest, lien, encumbrance, option, pledge,
security interest, mortgage, encroachment, obligation to offer or transfer, right of first refusal
or first option on transfer, or restriction of any kind, other than (i) Permitted Real Property
Encumbrances and (ii) as set forth on Schedule 2.3(a).

     “Environmental Laws” means shall mean all federal, state, local and foreign statutes,
regulations, and ordinances concerning public health and safety, worker health and safety, and
pollution or protection of the environment, including without limitation all those relating to the
presence, use, production, generation, handling, transportation, treatment, storage, disposal,
distribution, labeling, testing, processing, discharge, release, threatened release, control, or
cleanup of any Hazardous Materials, as such requirements are enacted and in effect on or prior to
the Closing Date.

     “Environmental Matters or Conditions” means violations of Environmental Laws or notices of
violations or investigations or threatened proceedings relating to same.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and any
successor thereto, and regulations and rules issued pursuant to that Act or any successor thereto.

     “Exceptions” means bankruptcy, insolvency, reorganization, moratorium and other laws affecting
creditors’ rights generally, limitations (including court discretion) upon the availability of
equitable remedies (including injunctive relief and specific performance) and usury laws.

     “GAAP” means United States generally accepted accounting principles, consistently applied.

     “Government Reimbursement Programs” means Medicare, Medicaid, the TRICARE program, and all
other similar federal, state or local reimbursement or governmental programs for which the Business
is eligible.

     “Governmental Authority” means any foreign, federal, state, local or municipal court,
legislature, quasi-governmental, executive or regulatory authority, agency, licensing or
accrediting body or commission, or other governmental entity, authority or instrumentality.

     “Hazardous Materials” means any substance by character or concentration defined in or
regulated under any Environmental Law to be a pollutant, hazardous substance, radioactive
substance, toxic substance, hazardous waste, medical waste, radioactive waste, special waste,
petroleum or petroleum-derived substance or waste, asbestos, polychlorinated biphenyls, or any
hazardous or toxic constituent thereof and includes, but is not limited to, any substance defined
in or regulated under any Environmental Law.

     “Hospital” means that hospital owned by the Seller, and which is the Seller’s principal place
of Business, located at 707 South Edwin C. Moses, Dayton Ohio, 45408.

     “Including” (whether or not capitalized) means for illustration but without limitation.

 - 3 - 

 

     “Indebtedness” means, without duplication, the sum of (i) all obligations of Seller for
borrowed money related to the Business and any accrued interest or prepayment premiums related
thereto, and (ii) all obligations of Seller as lessee(s) under Assumed Contracts that have been
recorded as capital leases in accordance with GAAP.

     “Investor Members” means (i) any individual (and the individual’s ancestors, souse, siblings,
lineal descendants; spouses of ancestors, lineal descendants and siblings; and any executor or
other representatives of such individual) that holds, directly or indirectly (through an
investment, membership or other interest in any corporation, partnership, limited liability
company, trust, association or other entity) an investment interest in Seller as of the Execution
Date, and (ii) any corporation, partnership, limited liability company, trust, association or other
entity (excluding MedCath and its subsidiaries) that holds, directly or indirectly, an investment
interest in Seller as of the Execution Date.

     “Knowledge” means that a particular fact or other matter will be imputed to Seller if any of
its trustees, directors, officers or Investor Members or MedCath: (a) is actually aware of the
fact or matter or (b) a reasonably prudent individual could be expected to discover or otherwise
become aware of notice of that fact or matter in the course of conducting his or her
responsibilities as a trustee, director, officer or Investor Member or in the conduct of its
business.

     “Legal Requirements” means any federal, state, local or municipal laws, ordinances, codes,
regulations, rules, orders, judgments, policies and guidelines or other legal requirements of any
Governmental Authority of the United States as in effect and interpreted on the date hereof, and
not as same or its interpretation may be subsequently changed or amended.

     “Liabilities” mean all indebtedness, claims, liabilities, obligations, responsibilities,
losses, damages, judgments, punitive damages, economic damages, treble damages, costs and expenses
(including, without limitation, reasonable attorney, expert, engineering and consulting fees and
costs and any fees and costs associated with any investigation, feasibility, or remedial action
studies), fines, penalties and monetary sanctions, and interest, whether accrued, absolute or
contingent, and whether or not of a kind required by generally accepted accounting principles to be
set forth on a financial statement or in notes thereto.

     “Losses” mean any and all Liabilities, damages, fines, costs, fees, penalties, deficiencies,
losses, amounts paid in settlement and expenses (including, without limitation, interest, court
costs, reasonable fees of attorneys, accountants and other experts or other expenses of litigation
or other proceedings) of a Party related to any claim, default or assessment described in, arising
under or otherwise relating to the Agreement or the transactions contemplated therein.

     “Material Contract” means each contract, agreement or other commitment (other than this
Agreement), or series thereof among the same parties, to which Seller is a party and (i) which
contains an obligation of any party thereto to pay at least One Hundred Thousand and No/100 Dollars
($100,000) in the aggregate, (ii) contains covenants of Seller not to compete in any line of
business, industry or geographical area or covenants not to solicit or hire any employee or group
of employees of any other Person that are currently in effect, (iii) relates to the acquisition or
disposition (by merger, purchase or sale of stock or assets or otherwise) by Seller of any of its
operating businesses or material assets or capital stock or equity interests; (iv)

 - 4 - 

 

which creates a partnership, limited liability company or joint venture or similar
arrangement; (v) under which Seller has made, or has agreed or committed to make, advances or loans
to any other Person (except for any business advances to employees in the Ordinary Course of
Business) or (vi) evidences Indebtedness or creates an Encumbrance.

     “MedCath” means MedCath Incorporated, a North Carolina corporation, together with its
Affiliates and Affiliated Persons.

     “Order” means any order, injunction, judgment, determination, decree, award, ordinance, ruling
or assessment of any Governmental Authority.

     “Ordinary Course of Business” means with respect to any Person the ordinary and usual course
of normal day-to-day operations of such Person consistent with past custom and practice in all
material respects (including with respect to quantity and frequency) of such Person.

     “Owned Real Property” means the real property and all improvements thereon which is owned by
Seller and which is being sold to Buyer pursuant hereto, and excluding any real property which is
an Excluded Asset.

     “Parties” means Seller and Buyer.

     “Person” means any individual, partnership, limited partnership, corporation, business trust,
limited liability company, limited liability partnership, joint stock company, trust,
unincorporated association, joint venture or other entity, or any Governmental Authority.

     “Proceeding” means any action, arbitration, audit, hearing, investigation, litigation, or suit
(whether civil, criminal, administrative, judicial or investigative, whether formal or informal,
and whether public or private).

     “Prohibited Territory” means the area within fifty (50) miles of the Hospital.

     “Seller ERISA Affiliate” means each trade or business (whether or not incorporated) which
together with any Seller is treated as a single employer under Section 414(b) or (c) of the Code.

     “Taxes” means any federal, state, local or foreign income, gross receipts, license, payroll,
employment, excise, severance, stamp, occupation, premium, windfall profits, environmental
(including taxes under Code § 59A), customs duties, capital stock, franchise, profits, withholding,
social security (or similar), unemployment, disability, real property, personal property, sales,
use, transfer, registration, value-added, alternative or add-on minimum, estimated or other tax of
any kind or nature whatsoever, including any interest, penalties or additions thereto, whether or
not disputed.

     “Title Commitment” means a title insurance commitment for an owner’s policy of title insurance
for a fee or leasehold interest, and such Commitment is to be issued by the Title Company.

 - 5 - 

 

     “Title Company” shall mean a nationally recognized title insurance company reasonably
acceptable to Buyer.

     “Title Policy” shall mean an owner’s policy of Title Insurance insuring good and marketable
title to the Owned Real Property and conveyed to Buyer hereunder, in the name of Buyer, issued by
the Title Company with liability in such amount as Buyer may reasonably determine to be the fair
market value of such Owned Real Property, and dated as of the Closing Date.

 - 6 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]